Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a S. Acosta,* J. Jernberg,* C. D. Sanberg, † P. R. Sanberg,* B. Small, ‡ secreted protein that reduces endoplasmic reticulum (ER) stress and C. Gemma,* § and P. C. Bickford* § exhibits neuroprotective effects. We have previously reported that exogenously administered recombinant MANF protein has neuroprotec-*Center of Excellence for Aging and Brain Repair, Department tive effects against cerebral ischemia in rodents (Airavaara et al., JCN, 2009 ). In the current study, we used an adeno-associated virus expressof Neurosurgery and Brain Repair and Department of Molecular ing human MANF (AAV-MANF) to examine the effects of enhanced, Pharmacology and Physiology, University of South Florida College endogenous MANF production in a rat model of stroke. AAV-MANF of Medicine, USF Health, Tampa, FL, USA or an AAV vector expressing the green fluorescent protein (AAV- †Natura Therapeutics, Inc., Tampa, FL, USA GFP) was administered into three cortical sites (AP −0.3, ML 5.5, DV ‡School of Aging Studies, University of South Florida College −3.5-−1.5, sites 1.5 mm apart) at a dose of approximately 1 × 10 10 of Medicine, Tampa, FL, USA viral genomes per site in chloral hydrate-anesthetized rats. Administra- §James A. Haley Veterans Affairs Medical Center, Tampa, FL, USA tion of AAV-MANF significantly increased MANF protein expression, as determined by immunostaining and Western blot analysis, at 1 week after injection. In another set of animals, the right middle cere-The process of aging is linked to oxidative stress, microglial activation, and proinflammatory factors, which are known to decrease cell bral artery (MCA) was transiently ligated with a 10-0 suture for 60 min at 1 week after viral injections. Immunostaining shows a redistri-proliferation and limit neuroplasticity. These factors may lead the transition from normal aging to more severe cognitive dysfunction associ-bution of MANF immunoreactivity 1 day after MCA occlusion. AAV-MANF pretreatment decreased infarction volume, body asymmetry, ated with neurodegenerative diseases. We have shown that natural compounds such as polyphenols from blueberry, and green tea, and and neurological score compared to animals receiving AAV-GFP. Western blot analysis shows that AAV-MANF reduces ischemia-amino acids like carnosine are high in antioxidant and anti-inflammatory activity that decreases the damaging effects of reactive oxygen induced expression of binding immunoglobulin protein (BiP), a key regulator of the unfolded protein response (UPR) . Given that MANF species (ROS) in the blood, brain, and other tissues of the body. Furthermore, we have shown that the combination of these nutrients is a highly conserved protein present in nematodes to humans, we further examined the function of the orthologous protein (MANF-1) (called NT020) creates a synergistic effect that promotes the proliferation of hematopoietic cells in vitro. We have also demonstrated that in Caenorhabditis elegans. Animals carrying a homozygous deletion in the manf-1 gene are viable and have a normal plate phenotype. NT020 protects the brain from ischemic damage and increases the migration of neural stem cells to the site of injury. In the present in vivo However, these animals exhibited increased basal expression from a UPR-inducible GFP reporter, specifically, a BiP homolog promoter. study, we investigated the natural therapeutic potential of NT020 for improving learning and memory in aged rats. We also examined the Furthermore, animals with the manf-1 deletion failed to show the nor-mal developmental arrest that occurs with chronic exposure to tunica-Characterization of a 19 F MRI Contrast Agent in Human NSCs for Transplantation Into Stroke-Lesioned Brain mycin, a chemical inducer of ER stress and UPR. Taken together, our data show that administration of AAV-MANF into rat cortex increases MANF production and reduces neurodegeneration induced by cerebral E. Bible,* B. Solanky,* E. T. Ahrens, † ‡ and M. Modo* ischemia. This protection may involve the ability of MANF to alter BiP protein, a key regulator of the UPR. Tracking transplanted cells in vivo by MRI provides a means to and M. Saarma* study transplanted neural stem cells (NSCs) and potential mechanisms of repair longitudinally after brain injury. Reliably detecting trans-*Institute of Biotechnology, University of Helsinki, Helsinki, Finland planted cells on MR images remains difficult, however, due to the †Faculty of Pharmacy, University of Helsinki, Helsinki, Finland relatively low resolution of MR images for detecting small numbers ‡Division of Neurobiology, Lund University, Lund, Sweden of cells and the lack of contrast between transplanted cells and intact §Neuroscience Center, University of Helsinki, Helsinki, Finland brain parenchyma. These problems can be overcome to some degree by the use of contrast agents to label cells prior to transplantation, but some of these have been found to adversely affect functional recovery. Parkinson's disease (PD) affects over 1% of people over age of Ideally, therefore, a contrast agent for clinical applications would not 60, has mostly unknown etiology, and is currently incurable. In PD contain metal particles to exert any deleterious effects on cellular funcmidbrain dopamine (DA) neurons and their striatal projections specifitions. We therefore investigated a bimodal 19 F contrast agent to label cally degenerate. The discovery of neurotrophic factors (NTFs) such human neural stem cells (hNSCs) for detection by MRI and fluoresas glial cell line-derived neurotrophic factor (GDNF), which can specent microscopy. A comparison of agent incorporation in three differcifically support the survival of DA neurons, raised hope for the conent hNSC lines in vitro indicated that cell viability only dropped marceptually new treatment for PD. GDNF, together with conserved dopaginally with increasing agent concentration, but was generally within mine neurotrophic factor (CDNF) and mesencephalic astrocytethe same range as control values. We also established that the addition derived neurotrophic factor (MANF), is the most potent NTF for DA of 10% serum to media was essential during agent incorporation to neurons known to date. Some data also suggest that GDNF reduction minimize the presence of excess extracellular agent that would give upon aging may be causative of PD. Whether this is the case is still a false positives during imaging. The extent to which the agent was inmatter of speculation. Phase I and II clinical trials with GDNF or its corporated into cells, however, differed depending upon cell line. Corhomologous protein neuturin (NRTN) for PD treatment have proved tical cell lines incorporated the agent, but a substantial amount rethe principle but the results vary substantially in efficacy and in extent mained extracellularly. In contrast, a striatal line incorporated the of adverse and side effects between different studies. A better underagent with minimal extracellular excess. These encouraging in vitro standing of GDNF biology in vivo may therefore help to improve its results now pave the way to evaluate the potential of this 19 F contrast therapeutic use. Currently some fundamental questions have remained agent for the long-term in vivo monitoring of transplanted NSCs in unanswered, including: (i) How does endogenous GDNF and its recepstroke-lesioned animals. tor GFRa1 affect the postnatal development of the brain dopamine (DA) system? (ii) Is embryonal or adult deletion of GDNF or GFRa1 sufficient to cause degeneration of DA neurons similar to Parkinson's Transplantation of Human NSCs on VEGF-Releasing disease (PD)? (iii) What is the role of GDNF and GFRa1 in maintain-Microparticle Scaffolds in a Stroke Model ing the adult DA system? (iv) Are there alternate receptors for GDNF in the brain? (v) What is the role of GDNF/GFRa1 in memory, learning, and behavior? The above questions have remained difficult to E. Bible,* D. Y. Chau, † M. R. Alexander, † J. Price,* address because knock-out (KO) mice lacking GDNF or its receptor K. M. Shakesheff, † and M. Modo* GFRa1 die at birth due to the lack of kidneys and enteric nerves, whereas most of the essential brain connections mature postnatally. At *Centre for Cellular Basis of Behaviour, Kings College London, birth, the DA system in GDNF KO mice is indistinguishable from the London, UK wt. To study the postnatal role of GDNF one has to generate GDNF †Division of Advanced Drug Delivery, Centre for Biomolecular and GFRa1 conditional KO (cKO) mice, where GDNF can be specifi-Sciences, School of Pharmacy, University of Nottingham, cally deleted (e.g., only in the brain, enabling us to bypass the neonatal Nottingham, UK lethality). To avoid possible compensation of the absent factor in the KO model by alternative factors frequently observed in the KO ani-After ischemic injury a cystic cavity is formed in the brain, surmals and to assess the impact of GDNF levels in mice over-or underrounded by damaged/dying cells. Stem cell transplantation therapies expressing the gene products of interest would be equally valuable.
have routinely involved injection of cell suspensions into the adjacent Here we report generation of GDNF and GFRa1 cKO mice and knockor contralateral surviving parenchyma. Although NSCs have been in mice overexpressing GDNF in naturally GDNF-producing cells shown to migrate to the site of injury, the cystic nature of the cavity (GDNF hypermorphs) as well as mice underexpressing GFRa1 in precludes reconstruction of lost tissue. Our previous work has demon-GFRa1 naturally expressing cells (GFRa1 hypomorphs). We report unstrated that NSCs can be transplanted directly into the lesion cavity on published results from the first-round analysis on the roles of GDNF a microparticle scaffold system with the aim of providing structural levels on postnatal brain function with the focus on the brain DA support within the lesion to promote tissue regeneration from transsystem.
planted cells. Nevertheless, there was a lack of blood vessel ingrowth into the transplantation site and lesion area, which may affect the longterm survival of transplanted NSC. To overcome this problem, we have transplanted NSCs on microparticles that secrete vascular endothelial growth factor (VEGF) directly into the cyst to increase vessel ingrowth and ultimately cell survival in the grafted area. We have assessed in vitro the cell viability, proliferation, and differentiation on VEGF microparticles and found no negative effect from VEGF re-human MSCs into the striatum of rats previously lesioned with 6-Acute Treatment of Herbal Extracts Reduces Ischemic Cell Death and Improves Motor and Neurological Functions hydroxydopamine (6-OHDA), a neurotoxin that induces profound neuronal loss in the nigrostriatal pathway. Following transplantation, a in Stroke Models relative amount of MSCs acquired a neuroglial phenotype, as expressed by immunopositivity for glial fibrillary acid protein (GFAP), C. V. Borlongan,* S. J. Yu,* Y. Kaneko,* H. Shojo,* E. C. Bae,* but only in animals bearing the nigrostriatal lesion. Transplanted ani-D. H. Park,* D. J. Eve,* P. R. Sanberg,* C. D. Sanberg, † mals showed increased survival of nigrostriatal dopaminergic neurons, P. C. Bickford,* ‡ B. Roschek, Jr., § and R. S. Alberte § which was associated with a reduction of the 6-OHDA-induced motor stereotypies (turning behavior). Increased survival of dopaminergic *Department of Neurosurgery and Brain Repair, Center neurons in transplanted animals was associated with enhanced levels of Excellence for Aging and Brain Repair, University of neurotrophic factors, such as brain-derived neurotrophic factor of South Florida College of Medicine, Tampa, FL, USA (BDNF) and glial-derived neurotrophic factor (GDNF), in the nigro- †Natura Therapeutics, Inc., Tampa, FL, USA striatal tract. These results support recent observations suggesting that ‡James A. Haley Veterans Affairs Medical Center, Tampa, FL, USA acquisition of a neuronal phenotype, by grafted MSCs, is not required for the beneficial effect to manifest; indeed, this effect may be based §HerbalScience Group LLC., Naples, FL, USA on the anti-inflammatory/trophic effects MSC are likely to exert through the release of soluble factors. Furthermore, in line with the Plant extracts have been indicated as potent therapeutic compounds view that triggering endogeneous neuroregeneration (neurogenesis) in a number of neurological disorders. Here, we examined the prophymay represent an alternative way to replace lost neurons, transplantalactic and restorative benefits of cacao and sage using both in vitro tion of MSCs promoted neurogenesis in the ependymal layer of the and in vivo models of stroke. For the in vitro study, we initially exsubventricular zone. In fact, rats that received the MSC graft showed posed primary rat cells to the established oxygen-glucose deprivation increased cell proliferation in this area, as indicated by the increased (OGD) stroke model followed by reperfusion under normoxic condinumber of cells positive for Ki-67 and proliferating cell nuclear antitions, then added different cacao and sage concentrations to the cell gen (PCNA), and enhanced migration of doublecortin-positive neuroculture media. Trypan blue cell viability results revealed specific cacao blasts toward the lesioned striatum. In conclusion, the use of MSCs in and sage dosages exerted significant therapeutic effects against OGDthe 6-OHDA model induced beneficial effects that may rely on multiinduced cell death compared to cultured cells treated with extract vehiple mechanisms, thereby supporting the therapeutic potential of this cle. Based on these robust poststroke restorative benefits of the exprocedure for PD.
tracts in the cell culture study, we next embarked on testing the therapeutic effects of cacao and sage extracts when treatment commenced either 1 h prior to or 1 h after transient middle cerebral artery occlusion (MCAo). Significant reduction in ischemic cell death within the Effects of Inflammation on Substantia Nigra Dopamine Neurons peri-infarct area coupled with better performance in routine motor and neurological tasks were demonstrated by stroke animals that received H. A. Boger, K. R. S. Reinert, and A.-C. Granholm cacao or sage extracts prior to MCAo compared to those that received the extracts or vehicle after MCAo. Taken together, these results dem-Department of Neurosciences and Center on Aging, onstrate that neuroprotective effects were afforded by plant extract Medical University of South Carolina, Charleston, SC, USA treatment, and that the in vitro stroke paradigm partially approximates in vivo efficacy when considering prophylactic treatment for stroke. Inflammation has been implicated in the pathology of several neu-
The novel finding here is that acute treatment (i.e., single oral adminisrodegenerative diseases, including Parkinson's disease (PD). Studies tration) of the extracts produces robust neuroprotection against stroke. using the endotoxin lipopolysaccharide (LPS), a potent inflammogen, P.R.S. and P.C.B. are cofounders of Natura Therapeutics. show that systemic insults can trigger prolonged microglial activation and proinflammatory cytokine production, leading to delayed and progressive death of substantia nigra (SN) dopamine (DA) neurons, mim-Alzheimer Amyloid-Beta Directly Inhibits Mitotic Kinesins: icking idiopathic PD. Therefore, the focus of this study is to assess Implication for Aneuploidy and Neuronal Plasticity time-dependent alterations in neuroinflammation, DAergic neurons, and neuronal signaling cascades in the SN following LPS administra-S. Borysov,* † J. Wu, ‡ § J. Padmanabhan,* † and H. Potter* † tion. In this study, high-dose LPS (5 mg/kg, IP) or saline (0.9% NaCl) was administered to 8-month-old male c57Bl/6 mice. At 1, 3, 5, and 12 h postinjection, the SN was assessed for tyrosine hydroxylase (TH, *Department of Molecular Medicine, University of South Florida, DAergic marker), Iba-1 (pan-microglial marker), phospho-Erk (extra-Tampa, FL, USA cellular signal-regulated kinases signaling), and phospho-CREB †USF Health Byrd Alzheimer's Institute, University of South (cAMP response element binding signaling). At 1, 3, and 5 h postin-Florida, Tampa, FL, USA jection, high-dose LPS resulted in a significant reduction in SN TH-ir ‡Department of Molecular Pharmacology and Physiology, University compared to saline controls, with a similar reduction in TH density of South Florida, Tampa, FL, USA observed at all three postinjection times. However, the high dose of §Electrophysiology Core at USF Health, University of South Florida, LPS (5 mg/kg) resulted in the greatest reduction of SN TH-ir at 12 h Tampa, FL, USA postinjection, compared to all other groups. In regards to neuroinflammation, the SN of high-dose LPS-treated mice had an increase in microglia activation at all postinjection time points, with the greatest in-Chromosome mis-segregation and defective neuronal plasticity crease in activated microglia observed at 5 h post-LPS injection. By implicated in Alzheimer's disease may result from amyloid-beta (Aβ)-12 h postinjection, high-dose LPS-treated mice exhibited activated as induced microtubule dysfunctions. Microtubule-based motors are critiwell as reactive microglia; the latter are known to produce inflammacal for the proper organization and functions of microtubule cytoskeletory cytokines that can result in toxic damage to neuronal populations. ton structures during a variety of cellular processes, including mitosis These data demonstrate that the initial reduction in TH immunoreacand the development of neuronal processes. Therefore, we hypothesize tivity observed after an LPS injection is not concomitant with morphothat Aβ abrogates functions of specific microtubule motors, thereby logical alterations in microglial cells. It is instead possible that the leading to aneuploidy and impaired neuronal plasticity. Aβ's interacinitial alteration in DA phenotype (TH reduction) may perpetuate an tion with motor proteins was studied by performing coimmunoprecipiinflammatory response that persists and leads to further DAergic tation and affinity purification. Aβ's effects on the motors' activities damage.
were studied in an in vitro microtubule-dependent ATPase assay. Aβ's This work is supported by NIA PO1 AG023630.
effects on the mitotic spindle were studied by using Xenopus egg extracts. Effects of the Eg5 inhibitor, Monastrol, on neuronal processes 334 ABSTRACTS were studied by using a long-term potentiation (LTP) assay. Aβ in-and infiltrating macrophages contribute directly to this process. We have developed an in vitro model in which adult rat dorsal root gan-duced defective spindle phenotypes, which are indicative of malfunctioning kinesin family motor proteins, Eg5, KIF4A, and MCAK. Con-glion (DRG) axons are confronted with a gradient of increasing inhibitory proteoglycan and decreasing laminin. Growth cones in this envi-sistently, Aβ directly associated with these mitotic motors, inhibited their activities in vitro, and abrogated their association with mitotic ronment develop a characteristic dystrophic morphology and, when contacted by activated macrophages, undergo dramatic axonal die-spindles. Interestingly, we showed that neurons express all of these motor kinesins, implying that their inhibition by Aβ may contribute to back. Endogenous NG2 + progenitor cells can stabilize axons after macrophage-mediated axonal dieback, but cannot prevent dieback. In this neuronal dysfunctions associated with Alzheimer's disease. In support of this, we showed that neuronal Eg5 is inhibited when neurons are study, we sought to determine if culturing DRG neurons with rat multipotent adult progenitor cells (MAPC) or MAPC-conditioned me-exposed to elevated concentrations of Aβ. Further, treatment of hippocampus slices with the Eg5-specific inhibitor Monastrol significantly dia (MAPC-CM) could prevent macrophage-mediated axonal dieback.
In the presence of MAPCs dystrophic axons became remarkably ac-reduced LTP readings to levels comparable to the exposure with Aβ. The data herein support a unified explanation for aneuploidy and de-tive. Macrophages contacted these axons extensively, but generally contacts were quickly broken and axonal retraction was prevented. Di-fective neuronal plasticity associated with Alzheimer's disease as resulting from Aβ direct inhibition of specific microtubule motors, in-rect addition of MAPC-conditioned media to the time lapse dish enabled growth cones to extend further into the inhibitory rim, and occa-cluding Eg5, KIF4A, and MCAK. sionally robust branching was observed. Macrophages still contacted these axons, but did not induce axonal retraction. To determine the growth-promoting capability of MAPC-CM in vitro, we compared dis-Adeno-Associated Viral (AAV) Vector-Mediated Gene Delivery sociated DRG neurons on a laminin substrate treated with MAPC-CM of Neprilysin Reduces A␤ Deposits in APP ؉ PS1 Transgenic Mice or control media and measured the longest neurite of every neuron. MAPC-CM-treated neurons exhibited a significant increase in out-M. Brownlow, N. Carty, D. Williams, K. Nash, M. N. Gordon, growth over control media and basal media conditions after 24 h. We and D. Morgan next sought to determine if MAPC could prevent axonal dieback or promote regrowth of injured axons in vivo in a dorsal column crush Alzheimer's Research Laboratory, Department of Molecular model of spinal cord injury. We transplanted MAPC into the spinal Pharmacology and Physiology, School of Biomedical Sciences, cord immediately following injury and measured axonal position at 2, University of South Florida College of Medicine, Tampa, FL, USA 4, and 7 days postinjury. The transplanted cells successfully integrated into the lesioned spinal cord tissue and associated with the endings Amyloid β (Aβ) deposition is one of the major neuropathological of injured axons. Four days postlesion, MAPC-transplanted animals hallmarks of Alzheimer's disease (AD), so reducing amyloid burden demonstrated a significant attenuation of axonal dieback normally obmay present a possible therapeutic strategy. One of the proteases inserved at this time. Seven days postlesion, MAPC-transplanted anivolved in the degradation of Aβ peptides is neprilysin (Nep). In this mals showed a significant increase in the extent of axon extension into study, we investigated the long-term effects of an intracranial administhe lesion core compared to vehicle controls. Our results suggest that tration of a recombinant adeno-associated viral vector (rAAV) ex-MAPC and MAPC-secreted factors prevent axonal dieback and propressing a Nep construct on amyloid deposition in APP/PS1 transgenic mote neurite outgrowth both in vitro and in vivo after spinal cord mice. Three constructs of Nep were employed. First, the native, meminjury. brane-bound form of Nep (Nep-N) was expressed under the control of the chicken β-actin promoter. In addition, a gene construct directing secretion of active Nep (Nep-S) and a gene construct containing a Cognitive and Sensorimotor Recovery After Fluid-Percussion single point mutation at the enzymatic active site precluding proteoly-Brain Injury Modified by Early Intermittent Stimulation sis (Nep-M) were created. The rAAV vectors were injected bilaterally for 1 Week in the Rat's Dorsal or Median Raphe into the anterior cortex and hippocampus of 7-month-old mice, while noninjected transgenic mice were used as controls. Brain tissue was M. M. Carballosa Gonzalez, L. Manoah, M. K. O'Connell, collected 9 months later when mice were 16 months of age. Immuno-O. Furones-Alonso, H. M. Bramlett, and I. D. Hentall histochemical data suggest a reduction in Aβ staining in the hippocampus of mice injected with either the native or the secreted form of Miami Project to Cure Paralysis, University of Miami, Miami, FL, USA neprilysin compared with mice that received the proteolytically inactive Nep. Additional analyses of other markers of amyloid and microglial activation are ongoing. These findings suggest that increasing the Our laboratory has previously shown that the medulla's raphe expression of the Aβ-degrading enzyme neprilysin through gene thermagnus, which has a highly branched descending serotonergic projecapy is a promising approach to the treatment of AD. tion, improves anatomical and behavioral recovery from an incomplete Supported by NIH grant AG 25509.
thoracic spinal contusion if stimulated for several days, starting within hours to a few days of the injury. We proposed that stimulation of divergent ascending serotonergic systems in the midbrain could have similar benefits in traumatic brain injury (TBI with two-way remote readout and control was cranially implanted 4-6 Cleveland, OH, USA h later. This delivered 5-min periods of alternating rest and stimulation †Department of Regenerative Medicine, Athersys, Inc., Cleveland, (−30 µA, 1-ms pulses at 8 Hz) for 12 h of daylight to a Pt-Ir micro-OH, USA electrode in the midline DRN or MRN. Some rats had inactive stimulators as controls. At 6 weeks, hidden platform spatial learning and working memory were measured in a Morris water maze, and forelimb There is substantial interest in stem cell transplantation after spinal cord injury. A phenomenon known as axonal dieback, the long-distance use asymmetry was quantified during rearing movement in a transparent cylinder, all assessed by ANOVA (p < 0.05) with Bonferroni post retraction of severed axons, occurs after many types of CNS injuries hoc comparison. Spatial learning in rats with TBI was superior on the Attenuation of Ischemic Brain Injury After Focal Cerebral Ischemia in Rat by Double-Stranded Adeno-Associated second trial day when the DRN or MRN was stimulated. Forelimb use symmetry also recovered more in stimulated groups. At 14 weeks, Virus 2-Delivered Vascular Endothelial Growth Factor brains were examined histologically. Anatomical analysis, presently confined to DRN, showed that stimulation bilaterally increased hippo-Y. H. Chiang, C.-F. Chang, † and K.-Y. Chen* † campal volume relative to cortex (30%). Furthermore, preliminary data have demonstrated an increase in cAMP following stimulation of the *Department of Neurosurgery, Taipei Medical University Hospital, MR. We propose that the enhanced sensorimotor and anatomical re-Taipei, Taiwan covery is due to a widespread release of serotonin, leading to the in- †Department of Neurological Surgery, Tri-Service General Hospital, crease in cAMP and the subsequent expression of neurotrophic and Taipei, Taiwan neuroprotective genes. In conclusion, sustained MRN or DRN activity can restore some kinds of motor and cognitive performance after TBI Vascular endothelial growth factor (VEGF) has been shown to disbut may also have adverse effects. Surgery and hardware for deep play neuroprotective effects in hypoxic-ischemic injury. Here, we inbrain stimulation (DBS) are readily adaptable to midbrain sites for vestigated the neuroprotective capacity of VEGF in a rat model of early TBI, but benefits and drawbacks in relation to outcome predicstroke. To increase the in vivo transduction efficiency in the brain, we tors (injury status, stimulation modality) need further assessment.
used a double-stranded adeno-associated virus 2 (dsAAV2) vector to Supported by USAMRMC W81XWH0810288. deliver VEGF. A single administration of dsAAV2 vector carrying VEGF (dsAAV2-VEGF) 7 days before the onset of ischemia effectively decreased the infarct volume and the number of TUNEL-posi-Blood-Brain Barrier (BBB) Dysfunction in Parkinson's tive, cleaved caspase3-positive, and fluoro-Jade B-positive neurons.
Disease (PD) Can Be Repaired and Provides Targeted
Next, we explored whether the dsAAV2-VEGF protected primary cul-Delivery to the Brain tures of cortical neurons from hypoxia. After infection of dsAAV2-VEGF in primary cortical neurons 3 days before 24 h of hypoxia, the P. M. Carvey, A. Patel, K. Collette, P. Roy, and B. Hendey number of surviving cells was significantly increased and the activation of caspase 3 was reduced. We further examined the signaling Department of Pharmacology, Rush University Medical Center, pathway of VEGF's neuroprotective activity, the expressions of Akt, Chicago, IL, USA extracellular signal related kinases 1 & 2 (ERK-1/-2), and p38 were analyzed. Cortical neurons infected with dsAAV2-VEGF showed in-We have previously demonstrated that treatment with several docreased phosphorylated Akt in hypoxia while the expressions of phospamine (DA) neurotoxins, including 1-methyl-4-phenyl 1,2,3,6 tetraphorylated ERK-1/-2 and p38 were without differences. These results hydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), rotenone, revealed that exogenous expression of VEGF by dsAAV2 vector could paraquat, and prenatal lipopolysaccharide, leads to dysfunction of the attenuate ischemic brain injury through activation of Akt. BBB in rats and mice and that human postmortem PD tissue indicates BBB dysfunction. This dysfunction is associated with increased paren-
Rearrangements of Plasmid DNA in Rodent Mesencephalic Cell chymal entry of several BBB integrity markers including FITC-labeled
Lines Produced by Transfection albumin (FITC-LA; rats and mice), increased expression of alpha-vbeta 3 integrin (αvβ3; a marker for angiogenesis; rats, mice, and hu-M. Coggiano, O. Dillon-Carter, J. Chen, S. Errico, and W. J. Freed mans), and is associated with microglial activation (rats, mice, and humans). We also have recently demonstrated that posttreatment of MPTP-treated mice with cyRGDfV peptide, which blocks αvβ3, pre-Cellular Neurobiology Research Branch, Intramural Research vented the FITC-LA leakage, αvβ3 upregulation, and microglia activa-Program, National Institute on Drug Abuse, National Institutes tion while preventing DA neuron loss (Patel et al. abstract this conferof Health, DHHS, Baltimore, MD, USA ence). This suggests that BBB dysfunction may be involved with the degenerative process and that the BBB dysfunction associated with
We have previously developed rodent CNS cell lines by transfecting primary cultures with truncated N-terminal variants of the SV40 toxin exposure can be repaired. We have also shown that MPTPtreated mice, but not control mice, exhibit increased entry of T cells large T antigen, from which the p53 binding C-terminal portion of the protein has been deleted (Truckenmiller et al., Cell Tissue Res., 1998) . and that the most profound entry was associated with T cells collected from MPTP-treated donors whereas less entry was observed from nor-
The purpose of the present study was to test the immortalizing properties of two versions of the N-terminal SV40 large T antigen fragment, mal donors. This suggests the involvement of the peripheral immune system in disease progression that is apparently facilitated by the ini-T155g, coding for small t antigen, and T155c, which does not code for small t, driven by either the respiratory syncytial virus (RSV) or tial dysfunction in the BBB. We just recently conducted pilot studies suggesting that the peripheral administration of 1-methyl-4-phenylpyr-elongation factor (EF1) promoters. Four plasmids were created: EF1-T155g, EF1-T155c, RSV-T155g, and RSV-T155c. Rat primary mes-idinium (MPP + ), a DA neurotoxin that normally does not enter the brain, led to further loss of DA neurons in MPTP-pretreated mice, encephalic cultures were transfected with one of the plasmids and maintained under neomycin selection for 1-3 weeks. Thirteen cell suggesting that the BBB dysfunction allowed entry of water-soluble toxins from the periphery. This is consistent with our prior studies lines were produced, one from the EF1-T155g plasmid (designated ETG1), five from EF1-T155c (designated ETC1-5), three from the where we demonstrated that domperidone as well as benserazide exhibited increased entry into the rat brain following 6-OHDA lesions.
RSV-T155g plasmid (designated RTG1-3), and four from RSV-T155c (designated RTC1-4). All cell lines could be propagated indefinitely. Taken together, BBB dysfunction in PD is emerging as a contributor to disease pathogenesis. Thus, an initial insult to the DA neuron leads While in log phase growth, many of the cell lines had a generally flattened, fibroblast-like appearance, while a few such as RTG1 and to inflammation that affects endothelial cells, leading to what appears to be compensatory angiogenesis and a breach of the BBB. This dys-RTC3 were more compact with fine cytoplasmic extentions. All cultures contained cells that were positive for nestin, neurofilament (NF), function can lead to increased entry of drugs as well as toxins that do not normally enter the brain as well as elements of the peripheral im-and β-III-tubulin, although in no case were cells uniformly positive for any of these markers. The cell lines varied considerably in their mune system, all of which can compromise effective therapy and/or mediate disease progression, respectively. Because the BBB dysfunc-properties; for example, RTC4 contained few nestin + cells but many NF + and β-III-tubulin + cells, while RTG1 contained large numbers of tion is punctate and encompasses only an estimated 1-2% of the nigra and striatum at any one time, this punctate leakage affords an opportu-nestin + cells but few NF + or β-III-tubulin + cells. All cell lines tested were positive for glutamate decarboxylase GAD67 and chemokine re-nity for targeted delivery of water-soluble therapeutics that would only enter areas of active inflammation where the BBB is compromised.
ceptor CXCR4, and negative for GAD65 by Western blotting. PCR was performed to examine incorporation of the various plasmid com-Supported by The Kenneth Douglass Foundation and NS052414.
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ABSTRACTS ponents into the cell's DNA. Six of the 13 lines were negative for Human Neural Stem Cells Repair Damaged Stroke Tissue. A Magnetic Resonance Imaging Study both T155c and T155g, and moreover only one cell was positive for incorporation of either of the two promoters, RSV or EF1. Only one cell line, RTG1, was positive for both oncogene and promoter. All cell M. M. Daadi,* J. Klausner,* R. Bhatnagar,* G. Sun,* B. Rutt, † lines were positive for the selection marker. Therefore, only fragments and G. K. Steinberg* of the immortalizing plasmid had been incorporated, suggesting that most of the cell lines had been spontaneously immortalized. Because *Department of Neurosurgery and Stanford Stroke Center, Stanford mutations in p53 have been proposed as the mechanism responsible University School of Medicine, Stanford, CA, USA for spontaneous immortalization of rodent cells, we examined the cell †Department of Radiology, Stanford University School of Medicine, lines for p53 mutations, and none were detected. We also examined Stanford, CA, USA the 13 cell lines for functional p53 activity, using a transfection assay with a plasmid containing the p21 promoter. Significant p53 activation Cell transplantation is a promising therapeutic intervention for huby adriamycin was detected in 7 of 12 cell lines tested, including man neurological disorders. Of clinical interest is the development of RTG1. Therefore, transfection does not consistently lead to incorporanoninvasive neuroimaging approaches to track transplanted cells and tion of complete plasmids under the present conditions. The reason for to monitor their survival and actions on stroke-damaged brain regions. partial plasmid integration is unknown; however, in the present study, These imaging technologies will be invaluable to research and develthe plasmids were linearized prior to transfection, while in previous opment of therapeutic strategies, as well as to stroke patient manageexperiments, linearization was not employed.
ment. In the present study, we used magnetic resonance imaging (MRI) Research supported by the IRP of NIDA, NIH, DHHS. to follow the stroke evolution and tissue repair and to track the fate of grafted human embryonic stem cell (hESC)-derived neural stem cells (NSCs) in the stroke-damaged brain. Self-renewable and multipotent NSCs were isolated from hESC based on their responsiveness to mito-Undifferentiated, Nonimmortalized Midbrain Neural Progenitor genic growth factors, including epidermal growth factor, fibroblastic Cells Promote the Survival of Mature and Developing growth factor, and leukemia inhibitory factor. The NSCs uniformly Mesencephalic Dopamine Neurons expressed nestin, vimentin, and 3CB2 (radial glial marker). For the MRI, cultured NSCs were incubated with MR-compatible contrast agent su-T. J. Collier,* C. E. Sortwell,* L. Madhavan,* B. F. Daley,* perparamagnetic iron oxides (SPIO) in the presence of poly-L-lysine K. Johe, † and K. L. Paumier* prior to cell transplantation for 3 days in vitro. To induce stroke, rats were subjected to middle cerebral artery occlusion for 65 min. Labeled cells were suspended at a concentration of 50,000 cells/µl and stereotax-*Department of Neurology, University of Cincinnati, ically grafted into the stroke boundary zone, 2 weeks poststroke. Graft Cincinnati, OH, USA survival was monitored using MRI on a weekly basis during the first 2 †Neuralstem, Inc., Rockville, MD, USA weeks and biweekly thereafter for 3 months. Volumetric analysis of the stroke and the NSC grafts demonstrated a marked diminution of the lesion over time. The precise locations of the stroke and grafts were The present study sought to determine whether undifferentiated, confirmed histologically using Prussian blue staining. The fate of the nonimmortalized, expanded neural progenitor (NP) cells promote the grafted cells was analyzed in confocal microscopy using the human nusurvival of mature and developing midbrain dopamine (DA) neurons clear marker in conjunction with various neural lineage markers, includin vitro and in vivo. First, we conducted several cell culture experiing nestin for neural precursors, glial fibrillary acidic protein for astroments utilizing NP cells derived from the developing rat midbrain cytes, β-tubulin for neurons, and galactocerebrocyde for oligodendroglial (mNP) to determine their effects on primary rat DA neurons. Results cells. Our study demonstrates that NSC grafts prevent tissue loss and from our in vitro studies indicate that undifferentiated mNP cells prothat MRI provides a reliable means to monitor and analyze in real time mote the survival of developing DA neurons by secreting soluble facthe stroke evolution in relation to NSC engraftment. tors that are supportive to DA neurons and sufficient to protect against toxin exposure. ELISA and Western blots detected significant levels of brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), Striatal Dopamine Innervation With Nigra Neurons in Parkinson and pleiotrophin (PTN) in mNP cell lysates, suggesting these factors
Patients as a Function of Disease Duration: Relevance to Trophic may be involved in the survival effects produced by undifferentiated Factor Therapy mNP cells. Next, we explored the potential of mNP cells to prevent the loss of mature DA neurons in an in vivo neuroprotection paradigm using a rat intrastriatal 6-hydroxydopamine ( Intraputaminal trophic factor therapy, especially the delivery of the genes or proteins for glial-derived neurotrophic factor (GDNF) or neu-intact side) and VEH (61% of intact side) conditions compared to the hMB condition (90% of intact side), which suggests that transplanted rturin, has been proposed as a therapeutic strategy for Parkinson's disease (PD). The common approach employed delivers the trophic factor hMB NP cells selectively protected host DA neurons. Our findings support the view that undifferentiated mNP cells express properties gene or protein to the terminal fields in the putamen where the therapeutic protein binds to receptors located upon remaining nigrostriatal that support neuroprotection and repair. Furthermore, our limited survey suggests that NP cells may differ in their properties based on the fibers. The trophic factor/receptor complex is then retrogradely transported to nigral perikarya where gene changes occur that invoke pro-region from which they are derived, and that those derived from midbrain may be optimal for repair of the where the status of the residual nigrostriatal system has been poorly ABSTRACTS 337 characterized. The present study examined the putamen of 24 PD cases modulated in the nigrostriatal sytem in response to 6-OHDA lesions and indicates that FA1/dlk may play an important role in Parkinson with disease durations between 1 and 27 years and compared the tyrosine hydroxylase (TH) and dopamine transporter (DAT) staining with disease. that seen in 10 age matched controls. In cases with 1-2 years' duration, the breadth and intensity of TH and DAT were similar and ap-Neonatal Tolerization: Long-Term Survival of Human Neural proached that seen in age-matched controls. In most cases in which Xenografts in Rat and Mouse Brain Without the Need disease duration was 3-4 years, there was a clear diminution in TH for Chronic Immunosuppression and DAT staining, but numerous fibers could be observed throughout the entire extent of the putamen. In cases of 5 years' duration or S. B. Dunnett, C. M. Kelly, and A. E. Rosser longer, there was a precipitous decrease in both TH and DAT staining. In all cases of this duration, staining for TH and DAT was limited to the occasional individual fiber throughout, at minimum, the dorsal half Cardiff University, Cardiff, South Wales, UK of the putamen and in most cases this staining pattern was seen throughout the dorsal three quarters of the putamen. In many cases Validation of human cells for clinical transplantation, whether priappreciable dopaminergic fiber staining was limited to the most venmary fetal tissues or stem cells, first requires demonstration of functral aspect of the putamen and to fibers traversing in the most medial tional efficacy in animal models of the human disease. For the grafts aspect of the putamen en route to the caudate nucleus. Optical density to survive, it is necessary to prevent rejection by the host immune measurements suggest profound DA innervation loss within 5 years of system, which is particularly challenging in "xenotransplantation" disease duration. These data, coupled with stereologically estimated across the species barrier. Effective immune suppression has traditionmelanin-containing and TH-ir neurons within the substantia nigra, supally been achieved either (a) by chronic treatment with immunosupport the concept that PD is an axonopathy and trophic factor therapy pressant drugs (such as cyclosporine A), although such drugs typically that relies exclusively on retrograde transport mechanisms and faces cause significant side effects on long-term administration, or (b) imsignificant challenges due to the absence of viable dopaminergic fibers planting into immunocompromised hosts (such as nude rats or mice), in all but the earliest PD cases.
although such animals are highly susceptible to infection and require full barrier maintainence. These constraints make both strategies unsuitable for long-term studies of cell survival, differentiation, and be-Increased Numbers of Fetal Antigen-1/Delta-Like Expressing haviour over more than 3 or 4 months. In order to evaluate alternative In this presentation we report on updated studies demonstrating equal Switzerland efficacy of tolerization in mouse as well as rat hosts. "Neonatal toleri- †Department of Anatomy & Neurobiology, Institute of Medical zation" involves inoculating the pups during the first postnatal week, Biology, SDU-Odense University, Odense, Denmark when their immune system is still developing, with tissues similar to ‡Department of Immunology & Microbiology, Institute of Medical that subsequently used for transplantation in adulthood. Typically, Biology, SDU-Odense University, Odense, Denmark 100,000 cells are injected IP on postnatal day P0 or P1, followed by implanting neural cells as a dissociated cell suspension into the brain The epidermal growth factor superfamily member fetal antigen 1/ when the pup reaches adulthood, 6-10 weeks following tolerization. delta-like (FA1/dlk) has been reported to be a growth and/or differenti-In the absence of neonatal tolerization, all grafts are fully rejected ation factor expressed in cells during development. Furthermore, FA1/ within 3-5 weeks. Chronic treatment with 10 mg/kg/day cyclosporine dlk has been demonstrated to be expressed in the ventral mesencepha-A yields ϳ75% surviving grafts over 12 weeks, but the drugs cause lon of rats and humans. The present study aimed at investigating the increasing side effects, requiring that the animals be euthanized on detailed expression pattern of FA1/dlk-immunoreactive (-ir) cells in welfare grounds. Following a single neonatal tolerization treatment, the midbrain of adult rats and in the 6-hydroxydopamine (6-OHDA) we achieve effective 87% transplant survival in the adult brain at 40 rat model of Parkinson's disease. For that purpose adult rats received weeks (the longest duration so far investigated). Tolerization is effeca unilateral injection of 6-OHDA either into the ascending mesotelentive with human hPF, hFNP, and hES cells in both rats and mice. Any cephalic pathway or into the striatum. One month later the brains were human brain tissue is effective-neonatal inoculation with hPF, hFNP, processed for histological analyzes. In line with our previous observaor hES cells permits equivalent levels of survival of human hPF, tions we found that FA1/dlk-ir cells were predominantly distributed in hFNP, and hES in any combination. Peripheral tissues (such as liver) the substantia nigra pars compacta (SNc) and ventral tegmental area.
are less effective. Although most studies have used human cortical Colocalization experiments revealed that most of the tyrosine hydroxytissue implanted into the intact striatum, we see appropriate differentilase (TH)-ir neurons also expressed FA1/dlk in the SNc, assuming that ation of striatal dopamine-and cyclic AMP-regulated phosphoprotein these cells are projection neurons. This latter assumption was further (DARPP + ) and tyrosine hydroxylase (TH + ) neurons within striatal and substantiated by colocalization of FA1/dlk with retrogradely transnigral hPF grafts in the relevant excitotoxic and 6-hydroxydopamine ported fluorogold injected into the striatum. The unilateral 6-OHDA (6-OHDA) lesion models. Neonatal tolerization now allows long-term lesions resulted in a marked loss of both FA1/dlk-ir and TH-ir neurons survival, differentiation, and function of various cell types transplanted in the SNc. Notably, this loss of FA1/dlk-ir cells was less pronounced to the brain over extended periods of time required for systematic dein the intrastriatally lesioned rats (by 50%) compared to animals with velopmental and behavioral analysis. lesions of the ascending mesotelencephalic pathway (by 85%). Accordingly, innervation of TH-ir and FA1/dlk-ir fibers was severely re-Purmorphamine Enhances the Neuronal Differentiation duced in the lesioned striata. Importantly, we detected that the number of a Human Striatal Neural Stem Cell Line In Vitro of striatal FA1/dlk-ir cells in the denervated striatum was significantly increased (by 70%) compared to the unlesioned side. The observation G. El-Akabawy, A. Jeffries, J. Price, and M. Modo that no TH-ir cells were detected in the denervated striata in response to the lesions reflects that these cells are not dopaminergic neurons. Moreover, our preliminary observations revealed that these FA1/dlk-Institute of Psychiatry, Kings College London, London, UK ir cells were not newly generated, indicating that FA1/dlk may be upregulated in already existing cells in response to the lesions. Taken Transplantation of neural stem cells is a promising therapeutic approach for neurodegenerative diseases including Huntington's disease together, our findings show that FA1/dlk expression is differentially 338 ABSTRACTS (HD). HD is an autosomal dominant neuropsychiatric disorder that that oxidative stress occurs in PD and little doubt that it leads to damage of the dopamine neurons that originate in the substantia nigra. leads to a progressive loss of medium-sized spiny neurons (MSNs) in the striatum. DARPP-32 (dopamine and cyclic AMP-regulated phos-Both methamphetamine and MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) are specifically toxic to nigrostriatal dopamine neurons phoprotein, 32 kDa) is transcribed in 98% of the MSNs. To establish an effective cell therapy for HD, the differentiation of human neural in the adult human and adult nonhuman primate through mechanisms involving oxidative stress. We have found, however, that in young stem cells (hNSCs) into more specific neuronal phenotypes is required. To this end, it is possible to use small molecules acting on particular monkeys, there is a marked resistance of dopamine neurons to both methamphetamine and MPTP. Specifically, we have found that meth-pathways involved in neuronal differentiation to enhance this process. By adding purmorphamine, a sonic hedgehog signaling pathway ago-amphetamine and MPTP significantly reduced striatal dopamine concentration (by 80% and 95%, respectively) in adults while causing no nist at a concentration of 1 µM for 7 days, we were able to significantly increase the neural differentiation of a striatal hNSC line significant loss in young monkeys. Altered pharmacokinetics do not appear to provide an explanation for these age-dependent differences, (STROC05) by nearly threefold. Conversely, this increase in neural differentiation was concomitant with a decrease in astrocytes (GFAP + as the same dose of methamphetamine actually results in higher CNS drug levels in the young monkey. The transient protection of dopamine cells). Upon long-term differentiation (21 days), purmorphamine further increased the number of neurons and also specifically increased neurons to neurotoxicity has raised interesting questions concerning differences in the induction and/or handling of oxidative stress in de-the number of DARPP-32-positive cells. These results indicate that small synthetic molecules, such as purmorphamine, can increase the veloping dopamine neurons. Thus, we are examining several specific mechanisms that would provide an explanation for the resistance of differentiation of NSCs. It is anticipated that enhancing DARPP-32 differentiation will eventually provide a more efficacious cell therapy young monkeys to methamphetamine and MPTP, as this may shed light on the plasticity and regenerative capacity of the dopamine sys-in animal models of HD.
tem at different stages of primate development, and provide drug targets to enable the early-in-life protection from damage to dopamine neurons to be reinstated later in life. Uncoupling proteins (UCPs) are Treatment Efficacy of Transplanted Human Striatal inner mitochondrial membrane proteins that regulate mitochondrial Neural Stem/Progenitor Cells in the R6/2 Mouse Model homeostasis. Recent evidence suggests that UCP2 plays a positive of Huntington's Disease physiological role by regulating reactive oxygen species (ROS) production, and that its activity is neuroprotective and antiaging. These G. El-Akabawy, I. Rattray, B. Solanky, R. Gale, G. Bates, data have led to the "uncoupling to survive" hypothesis of aging and M. Modo (Brand, Exp. Gerontol. 35:811-820; 2000) . We have examined the expression of mRNA for UCP-2 in the substantia nigra of adult and Institute of Psychiatry, King's College London, London, UK young St Kitts green monkeys by real-time PCR. A significant twofold higher expression of UCP2 occurred in young compared with adult Cell replacement therapies are currently a very promising new apmonkeys, suggesting that this might be a key protective mechanism in proach for the treatment of a wide variety of neurodegenerative disorthe young dopamine system that is suppressed later in life. Recent ders, including Huntington's disease (HD). To establish stem cell work (Andrews et al., J. Neurosci. 29:14057-14065; 2009 ) has shown transplantation as an effective therapeutic approach for HD, animal that administration of the hormone, ghrelin, protects against MPTP models that mimic the behavioral and histopathological disorder of toxicity by a UCP2-dependent mechanism. Thus, ghrelin may be a this disease are crucial. Transgenic R6/2 mice, expressing exon 1 of novel therapeutic UCP-dependent strategy to reduce dopamine neurothe human mutant HD gene, develop many aspects of human HD and degeneration that is associated with PD and aging. thus provide a suitable model to establish whether transplanted cells Supported by NS056181 (J.D.E.). can ameliorate this type of neurodegeneration. R6/2 mice of both sexes were randomly allocated into two groups (n = 10 each) either receiving unilateral stereotaxic injection of 120,000 human striatal neural Human Fetal Neural Stem Cell Transplantation for ALS: stem cells (hNSCs) into the striatum or a vehicle injection at 7 weeks A Phase I Safety Trial of age. A behavioral testing battery consisting of the rotarod, swimming T-maze, and passive avoidance was used to evaluate functional T. Federici,* J. Riley,* K. Johe, † T. Freeman, ‡ E. Feldman, § impairments over 6 weeks postgrafting. Magnetic resonance structural J. Glass,* and N. Boulis* imaging was performed prior to transplantation and at 13 weeks of age prior to perfusion fixation, in addition to spectroscopy prior to the *Emory University, Atlanta, GA, USA last time point. Transplanted cells did not improve motor impairments, †Neuralstem, Inc., Rockville, MD, USA but a significant improvement was observed on the swimming T-maze. Magnetic resonance spectroscopy revealed a trend of increased con- ‡University of South Florida, Tampa, FL, USA centrations of various brain metabolites (phosphocreatine, creatine, §University of Michigan, Ann Arbor, MI, USA taurine, and glutamine). Collectively, these results suggest that hNSCs have a potential to impact HD-related neurodegeneration, but that fu-Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuture refinement of the current study may be required to ensure a more rodegenerative disease characterized by rapid loss of muscle control efficacious therapeutic outcome. and eventual paralysis due to the death of spinal and cortical motor neurons. Preserving the survival of motor neurons in the spinal cord might prolong the survival of ALS patients. Neural stem cells derived from human fetal spinal cord have previously been shown to prolong Primate Dopamine Neurons: Uncoupling to Survive?
survival in animal models of ALS. When transplanted into the spinal cord of rodents, the grafted cells formed synaptic contacts on host J. D. Elsworth,* N. Wallingford, † S. Diano, † B. A. Morrow,* motor neurons and expressed multiple growth factors, including glia-R. H. Roth,* and D. E. Redmond, Jr.* derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). This trial will test the safety of the injection process *Department of Psychiatry, Yale University School of Medicine, and the implanted stem cells into the spinal cords of ALS subjects. New Haven, CT, USA
The strategy for cellular transplantation is derived from our collective †Department of Obstetrics and Gynecology, Yale University School experience with rodent and porcine spinal cord cell grafting and huof Medicine, New Haven, CT, USA man spine and spinal cord surgery, as well as the experience of others with human spinal cord transplant protocols. The use of a spine-mounted platform will ensure that no shearing occurs on the spinal cord. Excessive loss of nigrostriatal dopamine neurons is the proximate cause of Parkinson's disease (PD). There is overwhelming evidence
The initial cohorts of subjects will undergo lumbar injections in order to minimize the potential risks of transplant. Treatments will consist effects on the brain and cognition are not currently well understood. Previous work from our laboratory has shown that a 10% hydroge-of a dose escalation of 5 unilateral to 10 bilateral injections of 10 µl each into the lumbar enlargement. By injecting the cells at 3-4-mm nated coconut oil and 2% cholesterol diet resulted in impaired performance on the 12-day water radial arm maze, increased cholesterol and intervals, the intention is to deliver the therapy to multiple segments that are important to functional outcome. Once the subjects receiving triglyceride levels, and decreased dendritic microtubule associated protein 2 (MAP2) staining in the hippocampus. We have also recently the lumbar transplantation are shown to be safe, the same surgical approach will be extended to cervical enlargement of new subjects.
shown that each component of the "Western Diet" alone (saturated fat, trans fat, or cholesterol) resulted in alterations in hippocampal mor-Prior to and after the transplant, subjects will be required to remain on immunosuppressive therapy. Subjects will be followed until death.
phology and serum triglyceride/cholesterol levels. A reduction in dendritic integrity and fatty acid metabolism combined with an increase This is the first human stem cell trial to treat ALS in the US. in microgliosis as measured by antibodies against MAP2, 5-lipoxygenase (5-LOX), and OX-6 (MHC class II 1a), respectively, revealed Exploring a Novel Mechanism for Basal Forebrain Cholinergic damaging effects after just 8 weeks on the various diets. Our current Neuron Degeneration: Information Gained From a Mouse Model study has further evaluated the damaging effects of the "Western Diet" of Down Syndrome to cognition and hippocampal morphology using the 10% hydrogenated coconut oil and 2% cholesterol diet for 6 months starting at the A. M. Fortress,* M. Buhusi,* K. L. Helke, † and A.-C. Granholm* ‡ age of 7 months in Fischer 344 rats. We are further probing the mechanisms behind diet-induced damage to the brain and have found that *Department of Neurosciences, Medical University of South inflammation plays a role in altering the blood-brain barrier, allowing Carolina, Charleston, SC, USA cytokines to flood into the brain and cause damage. In this long-term study, serum was collected in order to analyze triglyceride and choles- †Department of Comparative Medicine, Medical University of South terol levels, inflammatory markers were measured, and immunofluo-Carolina, Charleston, SC, USA rescence studies on the hippocampus have been performed. These ex- ‡Center on Aging, Medical University of South Carolina, Charleston, periments have revealed a compromised blood-brain barrier, release SC, USA of interleukin-1 into the brain parenchyma, and dendritic damage for those animals receiving the hydrogenated coconut oil and cholesterol Down syndrome patients develop neuropathological hallmarks of diet compared to control. Together, this provides novel evidence for a Alzheimer's disease (AD) by their fourth decade of life; one such role of inflammation in diet-induced neurodegeneration. pathology is the degeneration of basal forebrain cholinergic neurons (BFCNs). BFCNs extend their axons to the hippocampus where they bind nerve growth factor (NGF) at its high-affinity receptor, TrkA. The NGF/TrkA complex is then endocytosed and retrogradely trans-Functional and Structural Impairment of Blood-Brain Barrier ported to the cell soma in the basal forebrain in order to promote in a Mouse Model of Sanfilippo Type B cholinergic neuron survival. Loss of NGF transport to the BF is correlated with both cognitive deficits and BFCN degeneration, posing an S. Garbuzova-Davis,* † ‡ § M. Louis,* R. Woods, III,* L. Wells,* important role for this system in memory processing in AD and Down S. K. Klasko,# and P. R. Sanberg* † ‡ § ¶ syndrome. Recent evidence has provided that the precursor to NGF, pro-NGF, is the predominant form of NGF in AD and is capable of *Center of Excellence for Aging and Brain Repair, University binding to the low-affinity NGF receptor, p75. This interaction preferof South Florida College of Medicine, Tampa, FL, USA entially activates cell death signaling by recruiting the coreceptor sor- †Department of Neurosurgery and Brain Repair, University of South tilin. Currently, the working hypothesis is that disrupted retrograde Florida College of Medicine, Tampa, FL, USA signaling of NGF/TrkA and failure of pro-NGF metabolism in certain disease states results in reduced trkA activation and elevated p75 re- ‡Department of Molecular Pharmacology and Physiology, University sponse, resulting in a propelling degeneration of the cholinergic neuof South Florida College of Medicine, Tampa, FL, USA rons. To better understand this mechanism, we conducted a life span §Department of Pathology and Cell Biology, University of South study in a mouse model of Down syndrome, the Ts65Dn, to determine Florida College of Medicine, Tampa, FL, USA how the TrkA to p75 ratio and upstream pro-NGF metabolism may ¶Department of Psychiatry, University of South Florida, correlate with behavior during aging and in a disease state. We exam-Tampa, FL, USA ined p75, TrkA, plasmin, and sortilin in 4-, 8-, 12-, and 18-month-old #University of South Florida College of Medicine, Tampa, FL, USA male normosomic and trisomic mice that were tested for memory deficits in the water radial arm maze. Based on previous work, we propose
In Sanfilippo syndrome type B (mucopolysaccharidosis MPS III that dysmetabolism of pro-NGF leads to preferential activation and B), a deficiency of alpha-N-acetylglucosaminidase (Naglu) enzyme upregulation of p75 that acts in concert with downstream NGF mechaleads to accumulation of heparan sulfate (HS), a glycosaminoglycan nisms to decrease the NGF/TrkA interaction and prevent the survival (GAG), within cells and to eventual progressive cerebral and systemic promoting signal in the BFCNs. To our knowledge, this is the first organ abnormalities. We have previously shown that human umbilical insight to modeling BFCN degeneration in a mouse model of Down cord blood cells ameliorated pathological changes after intravenous syndrome using the novel mechanism of pro-NGF-induced alterations.
(IV) injection into Naglu-deficient mice, probably due to continuous This work is supported by NIA AG012122.
delivery of the missing enzyme. Although administered cells were found widely distributed among different brain structures, the mecha-
Long-Term Treatment With a High-Fat/High-Cholesterol Diet
nism of cell migration to the brain is still unclear. One possibility is Compromises the Blood-Brain Barrier Leading to Increased that cell migration to lesioned areas of the brain occurs due to "signal-Inflammation and Hippocampal Damage ing" substances in damaged tissues, substances that attract the transplanted cells. Another possible mechanism of transplant cell migration L. Freeman* and A.-C. Granholm* † may be crossing of a damaged blood-brain barrier (BBB). However, no data exist about BBB condition in Sanfilippo. The aim of this study *Department of Neuroscience, Medical University of South Carolina, was to determine functional and structural BBB condition in a mouse model of Sanfilippo type B at different stages of disease. BBB func-Charleston, SC, USA tionality was determined by testing for vascular leakage with Evans †Center on Aging, Medical University of South Carolina, Charleston, Blue (EB) and albumin. BBB structural characteristics were identified SC, USA by electron microscopy (EM). EB dye was IV injected into Naglu mice to assess BBB integrity at early or late stage disease. Wild-type The "Western Diet" has been found to be a main culprit for obesity, type II diabetes, cancer, and cardiovascular issues. However, its mice (controls) were also injected at the same ages. After 30 min, mice were euthanatized and the brains examined for EB leakage. Im-flammation plays an important role in neuronal plasticity, as revealed by the fact that microglia toxicity and inflammatory cytokines are im-munohistochemical staining for albumin was also performed in serial brain sections. Results showed EB and albumin vascular leakage in plicated in the impairment in long-term potentiation (LTP), a model system for the neural mechanism underlying hippocampus-dependent various brain structures of early and late symptomatic Naglu mice, males and females. The majority of blood vessel leakage was detected memory, in aged rats. It has been shown that age-related increases in endogenous IL-1β (IL-1β concentration is accompanied by an im-in areas of the cerebellum, cerebral cortex, hippocampus, and midbrain. More leakage was found in late than in early symptomatic mice. paired expression of LTP). Consistent with this finding it has been demonstrated that IL-1β inhibits LTP in dentate gyrus, CA1, and CA3. Ultrastructural analysis of brain microvessels in Naglu mice showed severe damage to endothelial cells and pericytes. Additional immuno-To investigate whether CX3CR1 deficiency leads to impairment in other forms of synaptic plasticity we analyzed the induction and main-histochemical analysis for GM3 ganglioside in brain sections of Naglu mice revealed GAG accumulation within the vascular endothelium.
tenance of LTP in the CA1 region of CX3CR1 null mice (3 months old). Acute hippocampal slices were made from CX3CR1-deficient These results indicate functional and structural BBB damage in a mouse model of MPS III B. Diminished BBB integrity likely occurred mice and C57BL/6 mice. LTP was induced with high frequency stimulation (HFS). The HFS consisted of two 1-s pulses at 100 Hz separated due to GAG accumulation in endothelium of the brain microvasculature. Determining structural and functional BBB damage in MPS III by 20 s at half max with an interburst interval of 10 s. Following HFS, we recorded fEPSPs at half max for an additional 60 min. Our B is important not only for examining cell transplant migration, but is also crucial to understanding additional mechanisms of disease patho-preliminary data showed that deficiency in CX3CR1 causes a decrease in LTP. These findings further confirm our hypothesis that CX3CR1 genesis and to developing pharmacological and cellular treatments. Parkinson's disease (PD) affects 1 million Americans, and no of Florida, College of Medicine, Gainesville, FL, USA available intervention slows disease progression. Bilateral deep brain stimulation (DBS) of the subthalamic nucleus has gained acceptance as a safe, effective, and cost-effective treatment for the symptoms of In recent years, extensive evidence has shown that inflammation develops in the brain during aging and Alzheimer's disease (AD).
advanced PD. Recent studies mandate testing DBS in early PD because it (1) is more effective than medication alone, (2) may impart However, the causes and consequences of specific brain inflammatory responses are still not well understood. Fractalkine (CX3CL1), the neuroprotection, and (3) may prevent development or worsening of motor fluctuations. We are therefore conducting a single-blind, ran-CX3C chemokine, is the exclusive ligand for the CX3C receptor (CX3CR1) and has recently been identified as a key neuroimmune domized pilot trial in 30 patients with Hoehn & Yahr Stage II idiopathic PD, aged 50-75, who have been on medication for 6 months regulatory molecule. This chemokine is expressed on neurons while CX3CR1 is found on microglia, and the interaction between fractal-to 4 years. They must be without motor fluctuations or wearing-off, psychiatric disease, previous brain operation, or dementia. The in-kine and CX3CR1 is thought to maintain microglia in a resting state, thereby suppressing the neurotoxic activity of these cells. Decreased formed consent process includes four meetings with study physicians and completion of a questionnaire documenting study understanding protein levels of fractalkine have been found in the aged brain, as well as in the plasma of patients with AD. It is our hypothesis that a disrup-and reasons for participation. On day 1 of an 8-day inpatient medication washout evaluation, patients complete an 8-h ON/OFF diary, tion in fractalkine/CX3CR1 signaling is a key trigger of microglial activation during aging, which leads to cognitive impairment and sup-UPDRS testing, autonomic testing, and measures of gait in the ON state. Following completion of ON measures, subjects are washed out pression of neurogenesis. Recently we have shown that neurons and microglia are actively involved in a cross-talk to regulate the produc-and measured daily for 1 week. Subjects also undergo neuropsychological testing for adverse events and quality of life. Randomization tion of new neurons through Fractalkine/CX3CR1 signaling. Our study showed that loss of function of CX3CR1 in young adult rodents, mice [15 best medical therapy (MED), 15 DBS + MED] occurs after baseline evaluation. Identical follow-up inpatient evaluations occur at 6-and rats, resulted in a significant decrease in hippocampal neurogenesis, while the administration of exogenous fractalkine reversed the month intervals for 2 years. Subject enrollment was conducted from 2006 to 2009, during which 329 individuals contacted study personnel. decline in neurogenesis associated with aging. IL-1 receptor antagonist protected against the decrease in hippocampal neurogenesis induced Sixty-five attended information sessions, and 37 provided informed consent. Of these, one withdrew consent before baseline and six failed by blocking CX3CR1 function. The functional significance of adult neurogenesis is not fully understood. It has been suggested that the screening due to dementia (1), greater than Hoehn & Yahr II (3), abnormal MRI (1), and psychiatric disease (1). Participants who under-age-related decrease in hippocampal neurogenesis together with the decline in other types of synaptic plasticity contributes to a disruption went baseline are 28 males and 2 females, aged 60.0 years (range 50-74), who have been on medication 2.0 years (range 0.5-4). The in memory function. A great deal of evidence suggests that brain in-average full UPDRS score ON medication is 37.7. Participants' aver-Modeling Parkinson's Disease: Lessons From the Rotenone Model age UPDRS III scores are 14.4 ON medication and 26.9 OFF medication. To date, there are no withdrawals and 13 have completed partici-J. T. Greenamyre, J. Cannon, R. Drolet, E. Hoffman, M. Horowitz, pation. Most (80%) patients stated one of their top motivations to and P.-G. Mastroberardino participate was to benefit future patients, while for 40% this was the primary reason. Whether DBS is disease modifying remains highly *Pittsburgh Institute for Neurodegenerative Diseases and Department controversial among neuroscientists and neurologists, and will only be of Neurology, University of Pittsburgh School of Medicine, resolved in a carefully designed clinical trial. In our trial we achieved Pittsburgh, PA, USA rapid recruitment, and participants appear representative of early PD patients in general. The results of this trial, regardless of outcome, will
Our laboratory began to develop the rotenone model in the late improve the design of the definitive phase III trial. Any therapy that 1990s because there was a growing suspicion that Parkinson's disease reduces motor complications or positively modifies disease progres-(PD) might be associated with systemic mitochondrial defects. Rotesion will have a tremendous impact on the millions dealing with the none, unlike MPTP, produces uniform, systemic complex I inhibition. prospect of a relentlessly progressive disease.
To our surprise, chronic systemic inhibition of complex I-to a degree similar to that reported in platelets from PD patients-produced selective nigrostriatal degeneration. of the nigral ubiquitin-proteasome system (UPS) function with accuthe nigrostriatal system and, in combination with viral vector theramulation of poly-ubiquitinated proteins; accumulation of iron in the pies, possess therapeutic potential for Parkinson's disease (PD). Our substantia nigra through a mechanism involving transferrin and translaboratory and others have previously shown that the trophic factor ferrin receptor 2; α-synuclein pathology in enteric neurons and funcpleiotrophin (PTN), a 15.3-kDa cell surface and extracellular matrix tional deficits in gastrointestinal (GI) function, including gastroparesis. protein, is vital for the development, maintenance, and repair of the It is also worth noting that the transferrin-dependent mechanism of nigrostriatal dopamine system. Our goal is to optimize PTN gene iron accumulation we discovered in the rotenone model was subsetransfer in order to provide meaningful protection of the nigrostriatal quently found to be operative in human PD. In other words, the rotesystem in PD. We have previously demonstrated that striatal overexnone model predicted what we would find in PD. It is also worth pression of PTN that recapitulates peak developmental levels provides noting that, based on our initial report, epidemiological studies began significant neuroprotection for tyrosine hydroxylase-immunoreactive to look at the potential role of exposure to rotenone per se as a risk (TH-ir) neurons in the substantia nigra (SN), significantly increases factor for development of human PD. While the number of individuals TH-ir neurite density in the striatum, and can reverse functional defiexposed to rotenone and other "botanicals" is small compared to other cits in forepaw use following a toxic insult. Previous work utilizing classes of synthetic pesticides, a recent study found an odds ratio of glial cell line-derived neurotrophic factor (GDNF) gene transfer has 5.9 and another found an odds ratio for rotenone of 10.9. Thus, the shown that optimal functional restoration can be achieved via simultarotenone model informed subsequent epidemiological studies, which neous trophic factor overexpression in both the SN and striatum (Kirik have suggested a potential role for rotenone in some cases of PD. et al., 2000) . The present study was conducted to determine the opti-Given the apparent accuracy and predictive value of the rotenone mal PTN transduction site(s) within the nigrostriatal system for maximodel, we are now beginning to test pharmacological and viral-medimal neuroprotective and neurorestorative effects. Adult, male, Spragueated genetic therapeutic strategies for PD. Dawley rats were unilaterally injected in the striatum, SN, or both structures with recombinant adeno-associated virus serotype 2/1 (rAAV2/1) expressing either PTN and green fluorescent protein (GFP) or GFP alone. Four weeks following vector injection all rats received Parkinsonism in the Gastrointestinal Tract: An Open Window unilateral intrastriatal injections of 6-hydroxydopamine (6-OHDA).
in Mice and Man All rats were evaluated for extent of forelimb asymmetry prior to vector injection and immediately before and 4 weeks following the 6-J. G. Green,* † L. J. Cloud,* and A. R. Noorian* † OHDA injection. Stereological analyses of transduction volume, SN TH-ir neuron survival, and striatal TH-ir neurite density are ongoing.
*Department of Neurology, Emory University School of Medicine, Our results to date suggest that striatal PTN overexpression produced Atlanta, GA, USA by PTN gene transfer can provide morphological neuroprotection and †Center for Neurodegenerative Disease, Emory University School promote functional recovery in the nigrostriatal system. Pending reof Medicine, Atlanta, GA, USA sults will provide valuable information regarding optimal surgical PTN transduction parameters in order to inform our ultimate goal of testing the efficacy of PTN overexpression in PD patients.
Since its original description, Parkinson's disease (PD) has been known to be associated with dysfunction referable to multiple levels Supported by NS058682 (C.E.S.), the James J. and Joan A. Gard newed interest in nonmotor and other "nonnigral" aspects of the dis-342 ABSTRACTS ease (psychiatric and cognitive dysfunction, sleep abnormalities, auto-injections of kainic acid (KA). To reduce the mortality related to SE, diazepam (5 mg/kg) was injected at 1 h after the first stage V seizure nomic dysfunction, and digestive problems). Associated with this revival is the recognition that extranigral symptoms and pathology and rats were allowed to survive for 7 months. Another group of age-matched rats served as controls. The extent of chronic epilepsy must be taken into account when proposing experimental model systems and may provide unique opportunities for therapeutic interven-(characterized by behavioral spontaneous seizures) in these rats was measured via direct observation (8 h/week; 32 h/month) by two inde-tion in PD. We have recently begun investigating the effects of PD on the gastrointestinal (GI) tract in patients and various animal models of pendent observers. At 6 months post-SE, rats in both groups were examined for cognitive function using a water maze test (WMT). All parkinsonism. Our evidence confirms that GI symptoms are very common in PD patients and manifest early in the course of this chronic rats were perfused at the end of the WMT and the brain sections (every 20th section) through the hippocampus were processed for reelin im-neurodegenerative movement disorder. PD is associated with α-synuclein aggregation in the enteric nervous system (ENS) that lines the GI tract, munostaining. Following this, numbers of reelin + interneurons were quantified in each of the three regions in the hippocampus (dentate and enteric Lewy bodies appear to be more common in proximal GI segments. In parallel, we have examined several animal models of gyrus and CA1 & CA3 subfields) using the optical fractionator method in StereoInvestigator (Microbrightfield Inc.). While all KA-treated rats PD, including rotenone-treated rats, MPTP-treated mice, VMAT2 lowexpressing mice, and α-synuclein transgenic mice. Each model system developed chronic TLE characterized by SRMS, the frequency of SRMS varied between animals, which facilitated their classification has abnormalities in GI function, some that are concordant with those seen in PD and others that are not. Intriguingly, α-synuclein transgenic into rats with greater frequency of SRMS and rats with a lower frequency of SRMS. Stereological quantification revealed that the num-mice display an age-related decrease in gastric and colonic motility in the absence of overt or severe motor symptoms. The GI deficit does bers of reelin + neurons decline significantly in all three regions of the hippocampus in chronic TLE with maximal loss in the CA1 subfield. not appear to be related to either nonspecific GI pathology or neurodegeneration in the enteric nervous system. However, in mice of all ages,
The overall reduction was 34% in the dentate gyrus, 68% in the CA3 subfield, and 95% in the CA1 subfield. Comparison of the frequency there is accumulation of α-synuclein in and around the ENS similar in distribution and quality to that seen in human PD. Enteric synuclein of SRMS with the loss of reelin + interneurons did not suggest any link between these two phenomena in TLE, as rats with both greater and accumulation in transgenic mice mirrors Lewy body pathology in PD and GI innervation from the dorsal motor nucleus of the vagus nerve. lower frequencies of SRMS exhibited similar loss of reelin + interneurons. However, reelin + interneuron loss was greater in rats that exhib-Immunostaining approaches indicate that synuclein is colocalized with choline acetyltransferase, but not nitric oxide synthase or vasoactive ited significant impairments in spatial learning and memory function in the WMT. Taken together, these results suggest that while greater intestinal peptide, further supporting a possible vagal localization. The results implicate the vagus nerve as a potential modifier of GI dysfunc-loss of reelin + subpopulation of interneurons does not enhance the frequency of SRMS, it does have an adverse effect on memory function tion in parkinsonism. Given the extensive anatomical ramifications and multifaceted role of the vagus nerve, it may provide an intriguing tar-in the WMT. These results also imply that reduced reelin expression is one of the contributory factors to impaired learning and memory get for anti-parkinsonian therapies, not merely for GI symptoms, but for PD as a whole. Timely intervention may be facilitated by early function in chronic TLE. It is possible that reduced reelin mediates these effects via inappropriate migration of newly born neurons in the detection of GI dysfunction in animal model systems and vulnerable patient populations. dentate gyrus, resulting in loss of access to the learning and memory network for these newly born neurons. In this context, exogenous reelin application might be helpful for alleviating learning and memory dysfunction in chronic TLE. Whole genome analysis of major neurologic disorders is now concurrent motor seizures (SRMS) and cognitive deficits, is one of the sistently finding genetic risk factors for disease. In my talk, I will common neurological disorders. The morphological changes associdetail whole genome analyses of Alzheimer's disease (AD), Parkinated with chronic TLE include abnormal sprouting of dentate mossy son's disease (PD), motor neuron disease, and progressive supranufibers, reductions in the numbers of GABAergic inhibitory interneurclear palsy. I will make several points: (1) we are now able to find, in ons, astrocytic hypertrophy, and greatly waned dentate neurogenesis. a systematic fashion, any genetic risk factor for any neurologic dis-Reelin, an extracellular matrix glycoprotein expressed by most ease;
Links Between Loss of Reelin
(2) these analyses are beginning to show that in each disease, GABAergic interneurons in the cortex and the hippocampus, has been the risk factor genes map onto specific biochemical pathways; (3) shown to be reduced during the early phase of epilepsy (i.e., shortly some genes, and most clearly the tau (microtubule associated protein after an episode of acute seizures or status epilepticus). While reelin tau, MAPT) locus on chromosome 17, are risk loci for many diseases, is well known as a regulator of the neuronal migration and positioning including, for MAPT, PD and progressive supranuclear palsy cerin the developing brain, it is believed to have multiple functions in tainly, and AD (probably). I will discuss the unusual structure of the the adult brain. These include modulation of the synaptic plasticity, MAPT locus in European populations and speculate on its evolutionstimulation of the dendritic and dendritic spine growth, and the apt ary history and also describe that likely mechanism for its disease migration of newly born neurons in neurogenic sites such as the denassociation is through differences in gene expression between different tate gyrus and the subventricular zone. Because TLE is associated with MAPT haplotypes. substantial reductions in the numbers of different subclasses of GABAergic hippocampal interneurons, we investigated whether any link exists between the loss of a subclass of GABAergic interneurons that express reelin, the frequency of spontaneous seizures, and cognitive function in a rat model of chronic TLE. We induced status epilepticus (SE) in young adult male F344 rats via graded intraperitoneal
Overexpression of Glutamate Transporter (GLT1)
be detrimental to the cell. Dopamine exposure has been shown to be toxic both in cell culture and in vivo, causing selective damage to by Adeno-Associated Viral Vector Reduces Extracellular Glutamate Overflow and Cerebral Infarction After dopamine neurons that correlated with the extent of intracellular DA oxidation and protein modification. Exposure to dopamine quinone has Transient Middle Cerebral Artery Occlusion in Rats resulted in mitochondrial dysfunction, suggesting alterations in critical proteins. Recently, the Hastings' laboratory has utilized proteomics B. K. Harvey,* M. T. Airavaara,* J. Hinzman, † techniques such as two-dimensional gel electrophoresis and mass spec-M. J. Chiocco,* H. Shen,* D. B. Howard,* trometry to identify proteins modified by reactive metabolites of dopa-G. A. Gerhardt, † B. J. Hoffer,* and Y. Wang* mine. Results from our laboratory and others have identified critical mitochondrial proteins as well as familial PD-linked proteins as targets *National Institute on Drug Abuse, Baltimore, MD, USA for the dopamine quinone. Oxidative modification of proteins are †University of Kentucky, Lexington, KY, USA likely to lead to altered protein function, disrupted protein-protein interactions, accelerated protein degradation, and/or protein aggregation.
Neurodegeneration involves multiple cellular responses to injury
The susceptibility of certain proteins to modification suggests they or disease. Following an ischemic brain injury, one of the cellular may play a role in the vulnerability of dopaminergic neurons, as well responses that occurs is the excessive release of glutamate into the as the pathophysiology of PD, in general. extracellular space, which leads to excitoxicity and cell death. In the current study, we examined the ability of an adeno-associated viral vector expressing the rat glutamate transporter-1 (AAV-GLT1) to de-Electrical Stimulation in Rat Brain Stem Early After Spinal crease ischemia-induced elevation in extracellular glutamate and the Contusion Boosts Sensorimotor and Anatomical Recovery associated ischemic degeneration in the brain. We first characterized the AAV-GLT1 vector and confirmed protein expression by Western I. D. Hentall, S. S. Burns, M. L. Rodriguez, A. Irvine, L. Manoah,* blotting and immunostaining in primary cortical cultures. We next and M. M. Carballosa-Gonzalez demonstrated functionality of AAV-GLT1 by measuring glutamate clearance in the rat striatum. Sprague-Dawley (SD) rats received intra-*The Miami Project to Cure Paralysis, University of Miami School striatal injections of AAV-GLT1 or AAV-RFP (red fluorescent protein) followed 3 weeks later by in vivo electrochemical measurements of Medicine, Miami, FL, USA of glutamate clearance using a novel microelectrode array configured for L-glutamate. Animals that received AAV-GLT1 showed a signifi-Many neurotrophic or neuroprotective cellular and molecular cantly higher glutamate clearance rate compared to AAV-RFP injected mechanisms are known in mammals. Some, we propose, are under animals. After demonstrating the ability of AAV-GLT1 to alter extracoordinated central neural control and activated by signs of neurocellular glutamate levels, we tested the vector for neuroprotective eftrauma, such as pain or injury-released molecules. The serotonin-releasfects in a rat model of stroke. AAV-GLT1 or AAV-GFP (green fluoing brain stem nuclei may constitute such centers. Most spinal cord rescent protein) was administered to the right fronto-temporal cortex serotonin (5-hydroxytryptamine, 5-HT) is released by descending fiat three sites adjacent to the first bifurcation of the right middle cerebers from the nucleus raphe magnus (NRM). We stimulated the NRM bral artery (MCA). Three weeks after viral injection, the right MCA of unrestrained rats with a small (<2 g), cranially implanted wireless was transiently occluded (MCAo) by ligation with a 10-0 suture below stimulator through a tungsten microelectrode (impedance 0.5 megohm the bifurcation for 60 min. Two days after MCAo, infarction volume at 1 kHz). Stimulation began 1-2 h after a moderate weight-drop conwas measured by triphenyl-tetrazolium chloride staining in 2-mm tusion injury at segment T8 under isoflurane anesthesia. Monophasic brain sections. Animals receiving AAV-GLT1 had significantly less pulse trains (8 Hz, 1 ms, −30 µA; charge-density 1.5 nC/cm 2 ), using infarction than those treated with AAV-GFP. In a separate set of aniskull screws for anodal current return, were given in 5-min alternating mals at 3 weeks after viral injection, the tonic levels of extracellular on-off periods for 12 daylight hours for 1-8 days (mean 3.1). Motor glutamate in the lesioned cortex were measured using microdialysis recovery emerged significantly better than in controls. Thus, at 8 fractions collected at 20-min intervals starting from 1 h prior to weeks, Basso, Beattie & Bresnahan (BBB) score was 14.2 (n = 12), MCAo. MCAo increased extracellular glutamate levels, which were compared with 12.8 (n = 11) in rats with inactive implants and 12.5 significantly attenuated by AAV-GLT1, compared to AAV-GFP.
(n = 6) in rats without implants. BBB subscore, gridwalk speed, foot-Overall, our data support that AAV-GLT1 transduction can attenuate print (toe spread only), and fore paw mechanical allodynia (not hind ischemic injury, possibly through a reduction of extracellular glutapaw) similarly improved. More days of NRM stimulation gave a mate in the lesioned rat cortex.
greater increase in BBB score and subscore (rank order test, p < 0.05). Postmortem, at 14 weeks, myelin staining with Luxol fast blue 5 mm above the lesion (but not below) and 5-HT immunostaining 5 mm below the lesion (but not above) showed improved staining after NRM The Role of Dopamine Quinone-Modified Proteins in the stimulation; cavity and contused tissue sizes were unchanged. Identical Vulnerability of Dopaminergic Neurons in Parkinson's Disease stimulation (mean 5.9 days) in the periaqueductal gray (PAG), a major source of NRM afferents, raised 8-week BBB scores to 12.6 (n = 7) T. G. Hastings, V. Van Laar, A. Dukes, A. Mishizen, A. Mortimer, versus 11.2 in a no-implant cohort (n = 7). Footprint toe-spread was and D. Hauser significantly improved, but not gridwalk performance and not forelimb mechanical allodynia. Histologically, 14 weeks after spinal cord injury Pittsburgh Institute for Neurodegenerative Diseases and Department (SCI), total tissue around the injury segment was increased, and myof Neurology, University of Pittsburgh School of Medicine, elination was greater both rostral and (unlike with the NRM) caudal Pittsburgh, PA, USA by 5 mm from the epicenter; injury cavity and contused tissue volume was again unchanged. Analysis of 5-HT terminal density remains to be completed. We can account for these beneficial effects by a combi-Oxidative stress and mitochondrial dysfunction have been implicated in the pathogenesis associated with Parkinson's disease (PD).
nation of the following: (i) sustained enhancement of analgesia and motor pattern generation by raphe spinal activity, yielding rehabilita-Even though pathology in PD is not restricted to dopamine neurons, it is the dopaminergic neurons of the nigrostriatal pathway that are tional benefits; (ii) neuroprotective and neurotrophic effects of 5-HT, possibly mediated by 5-HT7 receptors and their elevation of cAMP most susceptible to degeneration in PD. The enhanced vulnerability of this population may be linked to the presence of dopamine itself, (preliminary findings show increased spinal cord cAMP with NRM stimulation); (iii) peptides coreleased with 5-HT, such as thyrotropin-where under oxidative conditions the catechol ring of dopamine will oxidize to form reactive oxygen species and dopamine quinones. The releasing hormone (TRH), which has documented benefits after SCI; (iv) NRM axons' greater intrinsic propensity to survive and regrow electrophilic quinones react readily with the thiol group of protein cysteinyl residues, resulting in covalent modification of proteins that may after SCI. The PAG effect is likely mediated by the NRM. The PAG is a safe, proven target for neurosurgical pain treatment by deep brain creased hyperexcitability of spinal dorsal horn neurons due to loss of inhibitory γ-aminobutyric acid (GABA)ergic interneurons. Previous stimulation (DBS), which suggests a potential treatment for early, incomplete SCI.
findings in our laboratory have shown that neural progenitor cells (NPCs) predifferentiated to a GABAergic phenotype can partially reverse neuropathic pain symptoms and reduce spinal hyperexcitability when transplanted into the dorsal horn of nerve-injured rats. hibited exaggerated responses to peripheral cutaneous stimulation. In animals with NPC transplants, WDR neuron responses to cutaneous How grafted neural stem cells (NSCs) and their progeny integrate stimulation were markedly reduced. Systemic (IP) or topical spinal into recipient brain tissue and functionally interact with host cells is application of BIC and CGP attenuated the antinociceptive effect of as yet unanswered. We report that, in organotypic slice cultures anathe NPC transplants, indicating a GABAergic-mediated antinociceplyzed by ratiometric time-lapse calcium imaging, current-clamp retion of the spinal transplants. Increased antinociception was observed cordings, and dye-coupling methods, an early and essential way in after injection of SKF 89976A in NPC-transplanted rats, suggesting a which grafted murine or human NSCs integrate functionally into host GABAergic-mediated mechanism of the transplants. By contrast, SKF neural circuitry and affect host cells is via gap-junctional coupling, 89976A alone had only a moderate effect in PBS-injected CCI rats. even before electrophysiologically mature neuronal differentiation.
These results suggest that a loss of spinal GABAergic inhibition medi-The gap junctions, which are established rapidly, permit exogenous ates nerve injury-induced chronic pain. A primary mechanism of the NSCs to influence directly host network activity, including synchroeffect of the transplants in the current study is release of GABA. Dinized calcium transients with host cells in fluctuating networks. The rect delivery of GABA to the spinal dorsal horn using cell-based or exogenous NSCs also protect host neurons from death and reduce such possibly gene therapy may be ideal for the long-term management of signs of secondary injury as reactive astrogliosis. To determine chronic pain. whether gap junctions between NSCs and host cells may also mediate Supported by NS51667. neuroprotection in vivo, we examined NSC transplantation in two murine models characterized by degeneration of the same cell type (Purkinje neurons) from different etiologies, namely, the nervous and Development of a Nonhuman Primate Model SCA1 mutants. In both, gap junctions (containing connexin 43) of Heart Dysautonomia formed between NSCs and host cells at risk, and were associated with rescue of neurons and behavior (when implantation was performed V. Joers,* † K. Seneczko,* N. Goecks,* T. J. Kamp, § K. Brunner,* before overt neuron loss). Both in vitro and in vivo beneficial NSC H. Simmons,* J. Holden,* ‡ and M. E. Emborg* † ‡ effects were abrogated when gap junction formation or function was suppressed by pharmacologic and/or RNA inhibition strategies, sup-*Wisconsin National Primate Research Center, University of porting the pivotal mediation by gap-junctional coupling of some modulatory, homeostatic, and protective actions on host systems as well as such as neurodegeneration of the autonomic nervous system resulting in dysautonomias, are missing and, in consequence, development of Therefore, there is a need for novel treatment approaches. One of the hypothesized mechanisms underlying chronic neuropathic pain is in-new treatments is difficult. In this study we aimed to develop a cardiac dysautonomia model in rhesus monkeys and generate a toolbox of yields significant behavioral and histological improvements over human embryonic stem cells (hESC) in a rodent model of Parkinson's methods that can be utilized to assess neurodegeneration in the heart and possible therapies. We hypothesized that systemic administration disease (PD). In comparison to hESCs, hUCBs are a heterogeneous population rich in hematopoietic stem and progenitor cells, lack ethical of 6-hydroxydopamine (6-OHDA) would induce cardiac dysfunction in the monkeys through neurodegeneration of the ganglionic catechol-implications, can be collected easily and noninvasively, are more immune immature than other adult stem cells, and have over two decades aminergic neurons innervating the heart. Five adult male rhesus monkeys (ages 5-7 years old, 7-9 kg) were evaluated before and after of history treating various clinical diseases. One concern about hUCB cells is their propensity to migrate out of the transplant site. The hy-intravenous administration of 6-OHDA through clinical evaluations, EKG, ultrasound, blood pressure monitoring, troponin, and catechola-pothesis is that combining transfection with a neurotrophic factor prior to transplantation with hUCB cells will enhance the retention, dopa-mine blood chemical assays. In addition, in vivo monitoring of neurodegeneration of the catecholaminergic terminals in the heart was achieved mine (DA) phenotype, and restorative properties of the cells at the graft site. The present study examined the effects of striatal CD133 with positron emission tomography (PET) using the nor-epinephrine analog 11 C-meta-hydroxyephedrine (MHED). Baseline PET scans of transplantation with and without pretreatment with striatal glial cell line-derived neurotrophic factor (GDNF) transfection. The specific the normal monkeys displayed normal MHED uptake in the heart wall, specifically a larger uptake in the left ventricle walls. PET images aim of our study was to determine the viability and potential of CD133s in a GDNF-enriched environment to repair, replace, or regen-obtained 7 days post-6-OHDA revealed an extensive decrease in MHED uptake that persisted up to 3 months, confirming loss of norad-erate the loss of DA in the striatum of bilaterally 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated parkinsonian-like primates. renergic innervation. These results suggest that intravenous administration of 6-OHDA induces neurodegeneration of catecholaminergic To test the hypothesis, cynomolgus monkeys (n = 10) were lesioned with both a right intracarotid and systemic injection of MPTP. The neurons innervating the heart and can be used to model heart autonomic dysfunction in PD. In future studies we plan to use the cardiac monkeys were symptomatically stable for over a year before being transfected with GDNF (n = 5) or needle sham lesioned (n = 5) 1 dysautonomia model to evaluate therapies. month prior to transplantion with CD133 stem cells (n = 10) into the right putamen. Timed arm-reach tasks and clinical rating scores on/off
Synuclein-Mediated Microglial Activation and Oxidative Stress:
L-dopa were performed weekly and before sacrifice. In this model of
Role for Pattern Recognition Receptor (PRR)
PD, at least 60% of DA neurons in the SNpc are lost, with greater than 80% depletion of DA levels in the striatum, and full PD-like D. Joseph,* J. Trecki,* E. Yehling,* H. Hathaway, † T. Mhyre,* motor deficits are observed by 3 weeks postlesion. One monkey from H. J. Federoff,* and K. Maguire-Zeiss* each group was sacrificed at 1 month after transplantation and the remainder at 4 months. The brains, livers, spleens, bone marrow, *Department of Neuroscience, Georgetown University Medical lymph nodes, and peripheral blood were taken from all primates for Center, Washington, DC, USA immunohistochemistry. Tissue sections were stained for tyrosine hydroxylase (TH), dopamine transporter (DAT), neuronal nuclei (NeuN), †Department of Pharmacology, Georgetown University Medical CD133 human nuclei (CD133), or double-labeled for DAT and CD133 Center, Washington, DC, USA for cell counts. All subjects demonstrated improvement in both behav-Parkinson's disease (PD) is an age-related neurodegenerative disioral assessments. The greatest statistically significant improvement order typified by the loss of substantia nigra pars compacta dopamine was ipsilateral to the graft. The most fundamental finding thus far is neurons (DAN), the presence of large proteinaceous synuclein-positive that, when transplanted into a GDNF-enriched striatum, more CD133 inclusions, and activated microglia. Evidence also exists for oxidative stem cells remain at the injection site. damage including lipid peroxidation, protein nitration, and changes in antioxidant defense mechanisms. The etiology of sporadic PD is still Hyaluronan and Laminin Hydrogels for Repair Strategies unknown, but several lines of evidence suggest that misfolded α-synu-After Cervical Spinal Cord Injury clein promotes inflammation and oxidative stress that engenders neurodegeneration. Recent work from our laboratory has demonstrated in Z. Z. Khaing,* 1 S. A. Geissler,* 1 T. Schallert, † R. J. Grill, ‡ synuclein transgenic mice increased microglial activation in the suband C. E. Schmidt* stantia nigra that markedly antedates DAN cell loss. This activation is thought to be the result of a direct interaction with α-synuclein be-*Department of Biomedical Engineering, The University of Texas cause cultured microglia are activated following treatment with αat Austin, Austin, TX, USA synuclein in a manner that is partially mediated through pattern recognition receptor (PRR) engagement. Here we show that various †Department of Psychology, The University of Texas at Austin, conformers of synuclein have disparate effects on microglia morphol-Austin, TX, USA ogy and PRR ligation. We also report an increase in antioxidant re- ‡Department of Integrative Biology and Pharmacology, sponse genes in the substantia nigra of synuclein-overexpressing mice
The University of Texas Health Science Center, compared with nontransgenic animals. This increase occurs as early Houston Medical School, Houston, TX, USA as 1 month of age prior to any neuropathological changes, suggesting that early oxidative events may incite later pathology.
Cervical spinal cord injuries (SCIs) can result in loss of hand functions, which are among the most devastating deficits in patients. Neurogenic niches of the adult brain contain various cell components, including neural stem cells, uncommitted and lineage committed neural progenitor cells, mature neurons, astrocytes, microglial, and en-Compensatory Response of Nigrostriatal Projections dothelial cells. Cells of the neurogenic niche express a variety of sigto ␣-Synuclein Gene Silencing in a Rat Model naling molecules, many of which have been shown to modulate prolifof Parkinson's Disease (PD) eration and differentiation. However, this neurogenic activity is spatially restricted to a very small portion of the brain. Despite much study, it C. E. Khodr, Y. Han, and M. C. Bohn appears that other brain regions, such as the functionally important cerebral cortex, do not produce neurons under normal conditions. This Neurobiology Program, Department of Pediatrics, Children's may be due to the absence of neural progenitor cells or the lack of Memorial Research Institute, Feinberg School of Medicine, supporting neurogenic signals in the nonneurogenic regions. A lack of Northwestern University, Chicago, IL, USA neurogenic signals is supported by the observation that neither migrating neuroblasts arising from neurogenic areas nor grafted neural progenitor cells differentiate into cortical neurons. We have identified the α-Synuclein (α-syn) gene mutations, multiplications, and promoter existence of endogenous immature proliferating cells within the entovariants have been linked to familial forms of Parkinson's disease rhinal cortex that remain phenotypically uncommitted. We hypothe-(PD). α-syn is an abundant protein in brain and a major component of sized that these cells remain uncommitted due to the lack of instructive Lewy bodies, intracellular inclusions characteristic of PD. We have differentiation signals in the mature cortical environment. To test this previously reported effective in vivo silencing of ectopically expressed hypothesis, we used a retroviral gene delivery approach to either suphuman (hu) α-syn in rat striatum and substantia nigra (SN) using lenpress glial fate or instruct neuronal fate. To suppress glial fate, a retrotiviral and adeno-associated viral (AAV) vectors, respectively, harborviral vector containing a dominant-negative form of Olig2 (Olig2 ing a hu α-syn-specific short hairpin (sh) RNA under control of the VP16-GFP; construct a gift from M. Goetz) was delivered to the ento-H1 promoter. In the SN, an unexpected reduction in tyrosine hydroxyrhinal cortex. Expression of the dominant-negative construct shifted lase (TH) immunoreactivity (ir) was observed in the region of the SN the fate of infected cells to production of astrocytic and neuronal phewhere hu α-syn was silenced. Nevertheless, hu α-syn gene silencing notypes relative to GFP expression alone. By 5 days of expression, reversed the hu α-syn-induced forelimb use deficit. These findings some 10% of infected cortical neural progenitor cells expressed the suggest a partial rescue effect of hu α-syn gene silencing on forelimb mature neuronal marker NeuN and appeared morphologically indistinuse despite an apparent toxic effect on dopamine (DA) cells. To furguishable from adjacent cortical neurons. Similarly, retroviral delivery ther investigate this conundrum, the effects of hu α-syn and silencing of Pax6 shifted the fate of infected cells to a neuronal phenotype relavector expression on distribution of DA projections to striatum were tive to GFP alone. In both cases, most of the resulting new neuronal studied. Adult, male Sprague-Dawley rats received a unilateral SN incells also expressed the neurotransmitter glutamate. Thus, there exists jection of AAV-hu α-syn and AAV-α-syn shRNA and striatal-projecta population of cortical neural progenitor cells that are susceptible to ing DA neurons were labeled using retrograde transport of fluorogold lineage instruction to produce neurons. As there is a series of instruc-(FG). One group of rats (prelabeled group) received bilateral striatal tive signals guiding cell fate during development, we expect that effi-FG injections 1 week before injection of AAV into SN to determine ciency of neuronal fate commitment will be improved by introducing whether treatment reduces the number of SN DA neurons that send a combination of signals in an appropriate temporal sequence. Ongoaxonal projections to a defined site in the striatum. Another group of ing work is investigating additional signal expression and assessing the rats (postlabeled group) received bilateral striatal FG injections 5 days longevity and functional integration of these newly produced neurons. before euthanasia to label DA neurons in the SN that send axonal Supported by NIH AG020047 and DOE DE2009174 to D.A.P. projections to the striatal site at the end of the experiment. Rats were euthanized at 9 weeks postinjection and brains were stained for TH-ir and hu α-syn-ir, and the numbers of FG-positive cells in SN were counted bilaterally. In the prelabeled group, FG-positive cells in the of Public Health and Health Professions, Gainesville, FL, USA 12.3%, p ≤ 0.05, n = 5) than in the prelabeled group (69.5 ± 8.8%, n = 4). These data suggest there is an initial toxic effect of hu α-syn and α-syn shRNA on nigrostriatal projections and that neighboring A significant potential for natural recovery exists within the injured spinal cord (SCI), and a challenge is to optimally interface thera-DA neurons respond by enhancing their projections to striatum. Ongoing experiments are examining the effects of treatments on DA levels peutic interventions with post-SCI neuroplasticity. This requires an understanding of the neural circuitry involved and the range of sponta-essential for normal mating behavior of female mice. These results suggest that SVZ-derived new neurons may take part in reproductive neous recoveries under different injury conditions. To address these issues, we have been investigating the spinal neural circuitry related function. The current study aimed at exploring the relationship between adult neurogenesis and male sexual behavior. Adult male to diaphragm function and respiratory changes following cervical SCI above or within the phrenic motoneuron (PhMN) pool. Neuroanatomi-Sprague-Dawley rats were treated with corticosterone and/or paroxetine (an antidepressant) for 2 weeks. These two drugs were shown to cal findings have demonstrated the presence of a population of spinal prephrenic interneurons (PINs), some of which receive descending suppress and promote neurogenesis, respectively. Mating behavior was assessed after the treatment, and bromodeoxyuridine immunohisto-projections from brain stem regions (VRC) subserving inspiratory drive to PhMNs. Correlative extracellular electrophysiological data chemistry was used to identify new cells. Neural circuit activation of the mating-related pathway was assessed by c-fos immunostaining. To suggest some PINs exhibit activity in phase with PhMNs and are responsive to hypoxic challenge in synchrony with elevated PhMN ac-further confirm necessity of neurogenesis in male mating behavior, inhibition of neurogenesis was performed by intracerebroventricular tivity. These data support the possibility that PINs may play a role in some aspects of spontaneous recovery of ipsilateral PhMN function infusion of cytostatic cytosine arabinose (Ara-c) and sexual behavior test was carried out. From cell quantification and mating behavior test, following a C2 hemisection lesion (C2Hx). To date, such neuroplasticity has been thought to be mediated entirely by uninjured, contralateral corticosterone treatment inhibited neurogenesis in the olfactory epithelium and SVZ, and simultaneously an inhibited sexual performance VRC fibers. Although there is a recovery of ipsilateral hemidiaphragm activity following C2Hx, prior findings suggest that ventilatory im-was found. Conversely, paroxetine treatment increased newborn neurons and enhanced the sexual performance in corticosterone-treated provement was modest. Diaphragm electromyography (EMG) recordings 12 weeks post-C2Hx also revealed little progressive change be-animals. When Ara-c was used to suppress neurogenesis, the sexual performance was suppressed. In addition, a decrease in cell prolifera-yond initial recovery, and anterograde tracing of VRC projections showed reduced innervation of ipsilateral PhMNs. To obtain a further tion was associated with a decreased level of c-fos expression in regions related to mating, including medial amygdala, bed nucleus of measure of respiratory drive to these neurons, experiments were performed in which ipsilateral (left) and contralateral (right) diaphragm stria terminalis, and medial preoptic areas. Taken together, the results suggest that neurogenesis plays a role in male reproductive behavior EMG activity was recorded following left or right phrenicotomies. Transection of the ipsilateral phrenic nerve resulted in a silencing of in rodents. Alteration of neurogenesis rate may be a potential treatment option for sexual dysfunction. left diaphragm activity, whereas a compensatory increase in EMG response was seen contralaterally. Contralateral phrenicotomy silenced 1 Both authors contributed equally to this work. the right hemidiaphragm; however, only a minimal change in left diaphragm EMG recordings was observed. Absence of a significant ipsilateral response suggests that ventilation in the C2Hx rat is more re-LPS-Induced Inflammation Exacerbates Phospho-Tau Pathology flective of compensatory rather than restorative neuroplasticity. We in rTg4510 Mice next explored to what extent respiratory function is affected after a clinically more representative contusion injury at the level ( notably amyloid-beta (Aβ) and hyperphosphorylation of tau activate microglia. However, it is less well understood how certain inflammatory events modulate Aβ and tau pathology. These studies were designed to elucidate the role of acute inflammation and its effects on Possible Involvement of Neurogenesis in Male Rat tau pathology. We used transgenic rTg4510 mice, which express the Mating Behavior P301L mutation (4R0N TauP301L) and initiate tau pathology between 3 and 5 months of age. We injected either saline or lipopolysaccharide inflammatory stimuli can facilitate tau pathology and that tau impacts University and The University of Hong Kong, GuangZhou, PR China the certain alternative activation markers. Coupled with prior results demonstrating clearance of Aβ by similar LPS injections, these results suggest that inflammation may have opposite effects on amyloid and Adult neurogenesis occurs in the dentate gyrus of hippocampus and subventricular zone (SVZ). Deficit of hippocampal neurogenesis tau pathology, possibly explaining the failures (to date) of anti-inflammatory therapies in AD patients. brings impairment of spatial learning and memory, which suggests the physiological role of new born neurons in memory formation. In con-This work was supported by P01 AG 04418, R01AG 15490, R01 AG18478, and P50 AG 225711, Alzheimer's Association (NIRG-06-trast, functional significance of new neurons born in SVZ remains elusive. Recent studies showed that neurogenesis in the SVZ is increased 27099), the NIA (AG031291), The Abe and Irene Pollin Fund for CBD from CurePSP. by pheromone exposure from the opposite sex and neurogenesis is 348 ABSTRACTS
Transfection of Dorsal Root Ganglia With Genetically
amyloid-beta (Aβ) peptide plays a critical role in the progress of this devastating disease. Stem cell factor (SCF) and granulocyte-colony Engineered Virus to Alleviate Peripheral Neuropathy: Antinociception via Intraneural Injection of Adenovirus stimulating factor (G-CSF) are the hematopoeitic growth factors regulating blood cell production and bone marrow stem cell mobilization.
-Conotoxin
Recently, we have demonstrated the therapeutic effects of SCF in combination with G-CSF (SCF + G-CSF) on chronic stroke. The pur-J. W. Lee,* S. Gajavelli, † D. Asmar,* and J. Sagen † pose of this study is to determine whether SCF + G-CSF can reduce the burden of Aβ deposits and to improve cognitive function in a *Department of Biology, William Paterson University, mouse model of AD. APP/PS1 mice were used as the mouse model Wayne, NJ, USA of AD. To track bone marrow-derived cells (BMDCs) in the brain, the †Miami Project to Cure Paralysis, University of Miami Miller bone marrow of the APP/PS1 mice was destroyed by 900 rad X-ray School of Medicine, Miami, FL, USA and was replaced with the bone marrow harvested from mice expressing green fluorescent protein (GFP) at the age of 7 months. Six weeks Pharmacological compounds provide minimal alleviation from after bone marrow transplantation, mice were randomly divided into a neuropathic pain, with a short-lasting effect. Recent human genetic saline control group and an SCF + G-CSF-treated group based on a data show ion channels play a major role in pain perception. Absence water maze test. SCF (100 µg/kg) + G-CSF (50 µg/kg) or equal volof gene encoding for voltage-gated Nav 1.7 renders patients incapable ume of saline was subcutaneously administered for 12 days. Circulatof sensing pain; abnormal expression causes development of erythroing bone marrow stem cells (CD117 + cells in blood) were determined melalgia. Neurotoxins that block opening of voltage-dependent calusing flow cytometry 1 day after the final injection. Nine months after cium channels, ω-conotoxin, also provide short-lasting alleviation treatment, spatial learning and memory were evaluated with the water from mechanical and thermal hyperalgesia. Synthetic conotoxin, Zicomaze test. At the age of 18 months, mice were sacrificed. Brain secnotide, is currently being used for pain management in terminal cancer tions were processed for immunohistochemistry to determine Aβ depatients. Advancements in molecular techniques permit insertion/ posits (4G8 antibody), microglia (Iba1 antibody), and GFP-expressing attachment of genes of analgesic neuropeptides to viral vectors. Sub-BMDCs in the brain. The level of CD117 + cells in peripheral blood dermal or intraneural injections will retrogradely transport the viralwas significantly elevated by SCF + G-CSF, indicating that the treatpeptide complex to dorsal root ganglia (DRGs) for continual replicament paradigm is effective in mobilizing bone marrow stem cells. In tion/synthesis of neuropetides using host nuclear machinery. The goal the water maze test, a significant short time in the escape latency was of the present study is to examine long-term usefulness of transfecting observed in the mice treated with SCF + G-CSF, suggesting that the the DRGs with adenovirus-ω-conotoxin complex to inhibit peripheral treatment induces a long-term improvement in spatial learning and nociceptive signal transduction and possibly activation of second-order memory. In histological data, we found that the number of senile nociceptive neurons in the spinal cord. Adult male Sprague-Dawley plaques was significantly reduced in SCF + G-CSF-treated mice and rats and C57/6J mice were injected with 2-5 µl of adenovirus-ωthat SCF + G-CSF-treated mice showed a significant high number of conotoxin complex into the left sciatic nerve. Seven days later, animals GFP-Iba1-expressing cells surrounding Aβ plagues, suggesting that were tested for formalin behavior. Intraplantar injection of formalin SCF + G-CSF treatment reduces Aβ deposits and that this reduction (5%, 30-50 µl) was made in the ipsilateral hindpaw, and the numbers may be through enhancing the clearance of senile plaques by bone of paw flinches were recorded at 5-min intervals for 60 min. Controls marrow-derived microglia. SCF + G-CSF treatment can delay AD received injections of adenovirus only. Animals were perfused transprogress by reducing the Aβ load and improving cognitive function. cardially with cold saline and paraformaldehyde solutions, and spinal These data would help in developing a new treatment to improve cords and DRGs were removed for ω-conotoxin peptide immunohistohealth of AD.
chemistry. The number of infected DRG neurons was correlated with
This study was supported by The Franks' Fundation and Louisiana the analgesic behaviors. Animals injected with ω-conotoxin expressed Gene Therapy Research Consortium. significantly fewer numbers of paw flinches during formalin phase II compared to control (conotox: 207 ± 53, control: 67 ± 22 In experiment 1, we hypothesized that EFF0311 will induce a longer duration of action and increased efficacy when compared to the equivalent DHX dose. Animals were treated with various doses of EFF0311 Alzheimer's disease (AD) is the major cause of dementia and the fifth leading cause of death in the elderly in the US. Although the (0.1, 0.3, and 1 mg/kg) or DHX (1 mg/kg) (n = 4 per group, SC). After injection, animals were tested for contralateral rotational behavior over cause of AD remains uncertain, substantial evidence shows that toxic ABSTRACTS 349 360 min. In experiment 2, we hypothesized that the rotational effects recovery: National Institute of Health Stroke Scale (NIHSS), European Stroke Scale (ESS), ESS Motor Subscale (EMS), and Barthel Index of EFF0311 are mediated by activation of D1 receptors, and that blockade of D1 receptors will prevent these actions. Animals were (BI). In this trial, all clinical information and evaluation data from each patient were assessed blindly by the data recorders and clinicians. initially treated with vehicle, D1 antagonist SCH39166 (1 mg/kg) or D2 antagonist remoxipride (3 mg/kg) (n = 2-3 per group). After 15
Patients have been followed for 12 months. The primary outcomes were assessed by group percentage changes between baseline and 12-min, animals were injected with EFF0311 at 1 mg/kg. Contralateral rotational behavior was monitored for 180 min. In experiment 1, we month follow-up in mean group scores on four clinical scales. As the secondary end point, we also assessed neurological functional activity found that EFF0311 induced a dose-dependent effect. Furthermore, 1 mg/kg of EFF0311 induced a longer duration of action and increased with 18 fluorodeoxyglucose positron emission tomography ( 18 FDG-PET) to measure the metabolic uptake of FDG, monitored the white matter potency when compared to the equivalent DHX dose. Average total number of rotations over 360 min was 4, 370, and 3,659 with 0.1, 0.3, tract integrity using diffusion tensor tractography (DTI) in MRI, and examined the electrophysiological conductance of corticospinal system and 1 mg/kg EFF0311, respectively. DHX (1 mg/kg) induced 1,026 total rotations (3× less than 1 mg/kg EFF0311). In experiment 2, the (CSS) of motor evoked potential (MEP) by transcranial magnetic stimulation (TMS) in the cortical areas surrounding the ischemic core. No D1 antagonist SCH39166 completely blocked EFF0311-induced rotation, whereas the D2 antagonist remoxipride slightly increased turning severe adverse effects were seen in G-CSF + PBSC-treated or G-CSFalone patients, who had received subcutaneous G-CSF injections (15 (1,972 vs. 1,370 for vehicle). These results suggest that EFF0311 has selectivity for D1 receptors and, compared to almost all earlier D1 µg/kg) for 5 consecutive days immediately after an episode of acute cerebral infarction. All patients completed the 6-month follow-up. In agonists, a longer duration of action. This combination of desirable pharmacological properties and longer duration of action may make the G-CSF + PBSC-treated group, we stereotactically transplanted about 4-8 × 10 6 CD34 + -immunosorted PBSCs through three trajecto-this compound very useful for studies of pharmacotherapeutic interventions in PD. For example, the relative role of different dopamine ries to the peri-infarcted area of the brain. The whole operative procedure of intracerebral implantation did not aggravate the inflammation receptor subtypes in the induction and/or reversal of drug-induced and graft-induced dyskinesias are controversial, and sometimes limited by and ischemia. According to the purity of CD34 + cells after immunosorting, we subdivided the G-CSF + PBSC-treated patients into two sub-the drugs available to study this critical aspect of current PD treatment. Future studies will investigate if EFF0311 can significantly ameliorate groups, including subgroup A: percentage of CD34 + cells >90% and subgroup B: percentage of CD34 + cells <90%. Compared to subgroup parkinsonism and reduce or prevent dyskinesias in preclinical models of PD, and how these behaviors are affected by D1 receptor activation.
B, G-CSF-alone, and control group, subgroup A of G-CSF + PBSCtreated patients achieved greater neurological improvement at the 12-In addition, it has been proposed that use of drugs with the properties of EFF0311 might also have antidegenerative effects that could slow month follow-up in NIHSS (G-CSF + PBSC group G-CSF group 59%, control group 36%), ESS (G-CSF + PBSC group G-CSF group 33%, progression of PD. EFF0311 thus represents a tool to advance our knowledge in these areas, and possibly lead to novel therapeutics for control group 20%), EMG (G-CSF + PBSC group GSF-group 106%, control group 58%), and BI (G-CSF + PBSC group G-CSF group PD.
Grant support: MH082441, MH040537, PA Keystone Innovation 120%, control group 60%). In a neurological functional activity assessment conducted with 18 FDG-PET, significant improvement in ce-Grant (R.B.M.) §University of Connecticut, Storrs, CT, USA of between 9 and 20. After determining eligibility, we randomly assigned them into three groups: G-CSF + PBSC implantation group (n = 15), G-CSF-alone group (n = 3), and control group (with usual While many studies have reported the clinical benefits of deep brain stimulation (DBS) on the motor symptoms of Parkinson's dis-care) (n = 15). The G-CSF + PBSC-treated and G-CSF-alone group received subcutaneous G-CSF injections (15 µg/kg per day) for 5 con-ease (PD), few have addressed the effects on speech. Some investigators have demonstrated improvements in speech, while others reported secutive days. The G-CSF + PBSC-treated group also received stereotactic implantation of CD34 + immunosorted PBSCs mobilized by either no effect or a worsening of the dysarthria. Furthermore, there is a lack of consistency in the methodological evaluation of speech as it G-CSF. We used the following clinical scales to assess neurological pertains to PD and DBS in particular. The goal of our project is to controls during water maze tests. In conclusion, these data suggest that SCF + G-CSF treatment can inhibit the pathological progress in create a computer-assisted algorithm to record and measure changes in speech with objective and quantifiable metrics. Our subjects include CADASIL mice by enhancing the cerebral blood supply, preventing CAA formation, and improving cognitive function. This study pro-PD patients who have been implanted with bilateral DBS electrodes targeting the subthalamic nuclei, as well as age-matched controls. A vides a new route for developing therapeutic strategies for improving health of CADASIL disease. total of 63 recordings have been obtained from 24 subjects: 17 PD patients with DBS and 7 controls. Speech was digitally recorded while
This study was supported by The CADASIL Foundation of America and Louisiana Gene Therapy Research Consortium. patients performed standardized speech tasks, including the recitation of individual polysyllabic words, semantically unpredictable sentences, and the rainbow passage. Identical tasks were performed before and after routine DBS adjustments. Speech samples were processed with a psychoacoustic bark filter bank, allowing direct comparison of Neural Precursor Cell Transplantation-Induced intensity changes over a range of frequencies. The intensity data were Neurogenesis and Neuroprotection: Underlying collected in 10-ms bins and signal averaged over a moving 50-ms Mechanics in the Parkinsonian Rat window. Rates of change in intensity were calculated as the difference between signal averaged intensities at 50-ms intervals, to avoid signal averaging interdependence. press). In particular, our work indicates that NPC implantation before the 6-OHDA insult can stimulate an endogenous NPC response, and that this response is associated with nigrostriatal neuroprotection and Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of amelioration of behavioral deficits (spontaneous paw placement in cylinder). Further, the transplanted NPCs expressed certain molecules inherited stroke and vascular dementia. This disease is caused by mutations of Notch 3 gene. To date, no drug can inhibit the progression [glial-derived neurotrophic factor (GDNF), sonic hedgehog (SHH), and stromal-derived factor 1α (SDF1α)] providing a potential molecu-of this disease. Recently, we have demonstrated that stem cell factor (SCF) in combination with granulocyte-colony stimulating factor (G-lar basis for the observed phenomenon. Currently, we are investigating mechanisms underlying the phenomenon by examining the roles of (a) CSF) (SCF + G-CSF) has therapeutic effects on chronic stroke. The aim of this study was to determine the effects of SCF + G-CSF on endogenous NPCs and (b) above-mentioned graft-expressed factors. Specifically, we are studying the role of endogenous NPCs, by inhibit-remodeling cerebral vasculature and improving cognitive function in a mouse model of CADASIL disease. Transgenic mice carrying ing host NPC proliferation and neurogenesis using cytosine-D-arabinofuranoside (AraC). Behaviorally, AraC-infused animals that were sub-the human mutant Notch 3 gene were used as the mouse model of CADASIL disease. To track bone marrow-derived cells, the bone mar-sequently grafted with NPCs performed significantly better on the cylinder task than sham controls, but were also significantly worse row expressing green fluorescent protein (GFP) was transplanted into CADASIL mice 1 month before SCF + G-CSF treatment. SCF + G-than NPC-grafted animals that had received no prior AraC infusion. Tyrosine hydroxylase (TH) cell counts through the substantia nigra CSF or an equal volume of saline was subcutaneously administered for 5 days and the same treatment was repeated an additional four support the behavioral data. These results indicate that endogenous NPCs are contributing, in part, to the observed NPC-mediated neuro-times with 1-4-month intervals. Spatial learning and memory were evaluated twice by a water maze test after the initial treatment. Mice protection. In parallel, the roles of graft-expressed GDNF and SHH are also being determined by using RNA interference (RNAi) tech-were sacrificed at the age of 21-23 months. Brain sections were processed for immunohistochemistry and immunohistochemical double niques. As a beginning step we have successfully designed and tested multiple short hairpin RNA (shRNA) constructs against rat GDNF, labeling was determined with confocal imaging. We observed that the cerebral blood vascular density in both cortex and striatum was signifi-moved the most efficient constructs into feline immunodeficiency virus (FIV) vector, and optimized viral infection and GDNF knock-down cantly increased by SCF + G-CSF treatment. In addition, the number of GFP-expressing cells in the corpus callosum and striatum of SCF + rate in NPCs. Also, shRNAs targeting SHH have been designed and tested for transfer into FIV. As a next step, NPCs in which either G-CSF-treated mice was greater than those of controls, and many of these GFP + cells also coexpressed endothelial marker, CD31. Interest-GDNF or SHH, or both, have been silenced will be transplanted into host rats to determine whether or not they contribute to the observed ingly, cerebral amyloid angiopathy (CAA) (CD31 + /4G8 + ) was also observed in the aged CADASIL mice, and the CAA was dramatically NPC-mediated neuroprotection and endogenous response to transplantation. prevented by SCF + G-CSF treatment. Further, the degeneration of smooth muscle cells on the small arterial wall was significantly inhib-Supported by NIH grant NS055295, NS58830 the Udall Center of Excellence in Parkinson's Disease Research at University of Cincin-ited in SCF + G-CSF-treated mice. Finally, SCF + G-CSF-treated mice spent a significantly shorter time to find the platform than saline nati, and The Gardner Family Center at the University of Cincinnati.
Identification of the Rostral Migratory Stream in the Canine
is the result of improved infection efficiency. Rather, the expression efficacy of infectious vector genomes is improved, thus requiring less and Feline Brain viral particles per cell to enable transgene detection. These results are promising in that the use of tyrosine mutant vectors provides for the S. Z. Malik,* M. Lewis, † M. Haskins, † T. Van Winkle, † use of lower titer viral preparations in the CNS. Consequently, the use C. H. Vite, † and D. J. Watson † of less viral particles may be beneficial if one considers potential immune responses that are known to occur by readministration of the *Department of Neurosurgery, School of Medicine, University viral capsids. Furthermore, if one considers the targeting of large volof Pennsylvania, Philadelphia, PA, USA ume areas in clinical applications, such as the caudate/putamen in Par- †Department of Clinical Studies, School of Veterinary Medicine, kinson's disease, improving transgene transduction properties certainly University of Pennsylvania, Philadelphia, PA, USA will be invaluable when a majority of this area needs to express the transgene. In the adult rodent brain, neural progenitor cells migrate from the subventricular zone (SVZ) of the lateral ventricle towards the olfactory bulb (OB) in a track known as the rostral migratory stream (RMS). A similar pathway has been described in other species but not in cats Compensatory Activity in the Phrenic Motor System Following and dogs. Here, we describe the RMS in canine and feline brains. Health Professions, University of Florida, Gainesville, FL, USA ating cells, progenitor cells, and immature neurons (Ki-67, nestin, and doublecortin), but not for NeuN, a marker of mature neurons. Identification and characterization of the RMS in canine and feline brain will It is well established that spontaneous recovery of ipsilateral diafacilitate studies of neural progenitor cell biology and migration in phragm function occurs in adult rats following complete lateral C2 large-animal models of neurologic disease. hemisection (C2Hx). This "restorative neuroplasticity" coincides with This work was supported in part by University of Pennsylvania a contralateral "compensatory neuroplasticity." The extent of ipsilat-Department of Neurosurgery funds (D.J.W.), NIH DK54481, eral recovery is limited, however, and its contribution to overall DK25759, and RR02512 (M.H.) , and the Ara Parseghian Medical Rebreathing behavior has not been extensively investigated. In addition, search Foundation (C.H.V.) .
little is known about possible associated changes in phrenic neural circuitry. Diaphragm activity ipsi-and contralateral to injury was assessed via electromyography (EMG) recordings at 2-12 weeks post-
Enhanced CNS Transgene Expression by rAAV Capsid
C2Hx and overall ventilatory function was evaluated at weekly inter-Tyrosine Mutants vals using plethysmography. Preliminary results show that restored ipsilateral function contributes modestly to ventilation following injury. Instead, contralateral activity plays a more significant role. This F. P. Manfredsson,* † W. W. Hauswirth, ‡ V. Chiodo, ‡ was confirmed by transection of the phrenic nerve (phrenicotomy) eiand R. J. Mandel* † ther ipsi-or contralateral to C2Hx. While ipsilateral phrenicotomy has little effect on respiration, contralateral phrenicotomy results in pro-*Department of Neuroscience, University of Florida, nounced ventilatory deficits. Combined anterograde and transneuronal Gainesville, FL, USA retrograde tracing [with biotin dextran amine (BDA) and pseudorabies †Powell Gene Therapy Center, University of Florida, virus (PRV), respectively] was used to examine changes in phrenic Gainesville, FL, USA circuitry following C2Hx lesions. Inspiratory drive to phrenic moto- ‡Department of Ophthalmology, University of Florida, neurons (PhMNs) derives from mono-and polysynaptic intraspinal Gainesville, FL, USA pathways from ventral respiratory column (VRC) medullary neurons. Injection of BDA into the VRC showed reduced bulbospinal input to PhMNs ipsilateral to injury, and associated prephrenic interneurons. Recombinant adeno-associated virus (rAAV) has proven to be a useful gene-transfer utility in the CNS. However, successful transgene Retrogradely tracing phrenic pathways ipsilateral to injury with PRV also revealed decreased connectivity between interneurons and PhMNs. expression is dependent on relatively high titer viral preparations. One significant limitation in the level of transgene expression is the ubiqui-In contrast, PRV tracing of the phrenic pathways contralateral to injury shows some recruitment of interneurons above the injury with projec-tination of viral capsid proteins. This phenomenon, occurring on tyrosine residues of the capsid protein, promotes degradation of the vector tions to contralateral PhMNs. These collective results reveal changes in the phrenic motor system contralateral to C2Hx that likely reflect before it reaches the nucleus, and interferes with transduction. Previous studies have shown improved transduction efficiencies utilizing compensatory plasticity and underscore its importance in maintenance of breathing postinjury. Studies aimed at enhancing PhMN recovery vectors containing mutations at these tyrosine sites, both in vitro and in various organ systems in vivo. Here we present the results from ipsilateral to C2Hx and optimizing restorative plasticity need to consider how such treatments also may affect compensatory plasticity. We striatal injections of rAAV type 2 expressing the green fluorescent protein (GFP) under a strong constitutive chicken β-actin/cytomegalohave recently begun studies using delivery of rolipram alone, or in combination with transplantation of neural progenitors, to promote re-virus enhancer promoter hybrid. Adult female Sprague-Dawley rats were stereotaxically injected in the striatum with 2 µl of vectors carry-pair and optimize functional recovery. Preliminary evidence suggests that rolipram delivery alone significantly improves respiratory out-ing capsid mutations ranging from a single tyrosine residue up to seven mutated residues. The results indicate that all mutated variants resulted come within 1 week post-C2Hx, but these effects do not persist. Combination treatment with cell transplantation suggests that respiratory in increased neuronal transduction spread, and increased GFP expression in transduced cells when compared to a wild-type rAAV2 control.
outcome can be enhanced 4-5 weeks postinjury, which may represent a more lasting functional improvement. In addition, several of the mutant combinations tested resulted in both anterograde and retrograde detection of GFP in various midbrain nu-Supported by Paralyzed Veterans of America (M.A.L.) , Anne and Oscar Lackner Chair (P.J.R.), and the NIH (R01 NS054025; P.J.R.) . clei. It is unlikely that the observed increase in transduction efficiency ficed and cervical/lumbar segments of the spinal cord were removed, h of treatment, IL-1β produced a statistically significant dose-dependent increase in GDNF protein [F(5, 23) = 7.33, p < 0.001, using Tu-fixed, and cut into coronal sections. Immunohistochemical staining of ramified microglia was performed using antibody IBA1 and staining key's post hoc] while TNF-α produced a dose-dependent decrease (p < 0.05) in GDNF. There were no observed dose-dependent changes of activated microglia was performed using MHC class II antibody OX6. Microglia density (MD) was measured in the gray matter of the in expression of BDNF. In conclusion, these results suggest that exposure to prenatal LPS results in increases in proinflammatory cytokines ventral horn region of spinal cord for both cell types. The spinal cord MD was compared between cell-treated, nontreated (media injected), within MS, AF, and brain that can impact the expression of GDNF. Alteration of neurotrophic factors, such as GDNF, during this critical nontreated [cyclosporine (CsA) injected], and C57BL/6J control mice. Consistently reduced ramified microglia density was noted in mice period of nigrostriatal pathway development could result in altered DA cell development, leading to permanent cell loss. Future studies will receiving 25 × 10 6 cells in both the cervical (p < 0.01) and lumbar (p < 0.05) spinal cord. ALS mice injected with the 10 × 10 6 or 50 × further explore the mechanism whereby proinflammatory cytokines alters neurotrophic factor expression in the developing nigrostriatal 10 6 cell dose showed no significant differences from nontreated G93A control mice. Surprisingly, exceptionally higher microglia densities pathway.
Supported by DOD and the Kenneth Douglass Foundation. were observed in mice receiving 50 × 10 6 cells, similar to densities in the nontreated G93A mice, possibly due to an immune conflict between microglia and the MNC hUCB cells introduced. Anticipated Functional Significance of Soluble Versus Membrane-Bound results should show reduced activated microglia density among mice Forms of Fractalkine receiving 25 × 10 6 cells. Our results confirm that the 25 × 10 6 MNC hUCB cell dose, previously shown most beneficial in regards to mouse J. Morganti,* † K. Nash, § A. Bachstetter, ¶ P. Bickford, † ‡ lifespan and disease progression, also provides the most anti-inflamand C. Gemma † ‡ matory benefit through inhibition of activated microglia. In the context of aging and neurodegeneration, prolonged microg- ‡National Health Research Institute, Taiwan lial activation has been shown to contribute to and further exacerbate Parkinson's disease (PD) is estimated to affect 4 million people pathological conditions. It is therefore relevant to examine molecular worldwide. While treatments are available to address the symptoms of signaling that may alter or reduce the levels of activated microglia. PD, the etiology of the disease is still up for debate. Nonfamilial PD Chemokines generally function as chemotactic mediators of cells with studies have been approached from the standpoint of adult exposures, corresponding receptors. Fractalkine (FKN) is unique among the suggesting that the etiology of PD begins in adulthood. Data from our chemokine family due to its ability to exist not only as a soluble factor laboratory, however, support the idea that prenatal exposures may be but also in a membrane-bound form. FKN signaling is achieved via risk factors for PD. When gravid female rats were exposed to the bactits sole receptor CX3CR1, which in the brain is expressed primarily erotoxin lipopolysaccaharide (LPS) at embryonic day 10.5 (E10.5), in microglia. Through its dual characteristics as a chemokine (soluble offspring were born with reduced numbers of dopamine (DA) neurons, and membrane bound) FKN-CX3CR1 signaling may factor into preless striatal DA, increased DA activity, and life-long increases in tuserving a resting phase of microglia. Recently, we have shown that mor necrosis factor-α (TNF-α) and increased numbers of microglia.
an inhibition FKN-CX3CR1 signaling increases activated microglia In vitro studies from our lab suggests that prenatal LPS exposure at leading to a disruption in neurogenesis. Furthermore, in vitro models E10.5 alters the ability of the DA neurons to develop process extenhave shown FKN ability to regulate known proinflammatory molesions necessary to reach neurotrophic-rich target regions and that an cules such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α alteration(s) in a soluble factor(s) expressed within both the develop-(TNF-α), thus acting as a potential anti-inflammatory signal. Curing mesencephalon and striatum may be responsible for the effect. The rently, little is known regarding the signaling functions of these two mechanism through which these effects occur, however, is unknown.
forms of FKN. To elucidate differences in action among these forms, We hypothesize that prenatal LPS exposure within the gravid female three AAV9 vectors, each encoding one of three types of mouse FKN, rat leads to elevations of proinflammatory cytokines such as interleunative (nFKN), membrane-bound (mFKN), and soluble (sFKN), were kin-6 (IL-6), IL-1β, and tumor necrosis factor-α (TNF-α) and in turn created. These vectors were examined for their differential role in effects development of the nigrostriatal pathway by altering the exmodulating inflammation and neurogenesis. pression of neurotrophic factors. We exposed gravid female rats to In addition, nigrostratial cocultures were established from tissue harvested at E14.5 and 72 h later were exposed to various doses of IL-6, IL-1β, and TNF-α to University of Minnesota, Minneapolis, MN, USA assess the effects of proinflammatory cytokines on expression of neurotrophic factors, glial-derived neurotrophic factor (GDNF), and brain-Current treatments for lysosomal storage disorders involve enzyme replacement therapy (ERT) such as iduronidase (IDUA) for treating derived neurotrophic factor (BDNF). The results indicate that after 24 354 ABSTRACTS Hurler's syndrome. This approach can ameliorate systemic deficits, Spinal cord injury (SCI) pain is clinically difficult to treat and few effective treatments exist. Marine cone snails produce numerous but current ERT delivered intravenously does not allow therapeutic enzymes to cross the blood-brain barrier, and thus patients such as selective and potent peptides that have CNS activity, and several have shown promise for treatment of severe pain. FDA-approved Prialt those with Hurler's syndrome continue to exhibit progressive deterioration in cognitive performance. An alternate approach for correcting is a synthetic version of naturally occurring peptide ω-conotoxin (MVIIA) found in the piscivorous marine snail Conus magus. Another enzyme deficiencies in the brain associated with lysosomal storage disorders is the delivery of genes encoding the enzyme of interest into peptide conantokin G (Con G) from Conus geographus has been a subject of Phase I clinical trials. Both these peptides are significantly the brain using nonreplicating viral vectors. In the present study we examined the biodistribution of the adeno-associated viral vector antinociceptive when injected intrathecally in rat pain models. ω-Conotoxin specifically blocks the presynaptic N-type Ca 2+ channels AAV5 to deliver the gene encoding fluorescent protein (GFP) for visualization within the central nervous system. AAV5-GFP was injected (Cav2.2) while Con G blocks postsynaptic N-methyl-D-aspartic acid (NMDA) receptors. However, continuous administration of pharmaco-stereotaxically into the right lateral ventricle of 5-day-old mice or adult mice. The brains of these animals were examined at 4 months after logical agents is often associated with undesirable side effects. Recent findings in our laboratory indicated that an intrathecal combination of injection to determine the biodistribution of GFP-expressing cells in different regions of the central nervous system. We observed that Con G and MVIIA resulted in robust synergistic antinociception without attendant motor side effects in a SCI pain model, in contrast to AAV5-GFP expression was more extensive when injected into the ventricles of neonates compared to adults. Areas of brain with high additivity in other pain models. These findings suggest that SCI pain is uniquely vulnerable to this peptide combination, and may be good expression of AAV5-GFP for both groups include the hippocampal formation, striatum, olfactory bulb, frontal cortex, and in ependymal candidates for gene therapy in SCI pain management. To explore the recombinant potential of these peptides, viral constructs that encode cells surrounding the ventricles. Our results demonstrate that AAV5 can achieve a widespread distribution within the central nervous sys-ω-conotoxin MVIIA and Con G were generated. MVIIA is amidated; hence, the cDNA was ligated to the signal sequence of mammalian tem when injected into the ventricles of the neonatal and adult brain, and may therefore be suitable as a vector for gene delivery to correct amidating enzyme, peptidyl α monooxygenase (ssPAM), in order to facilitate correct processing and packaging of the active peptide. Glu-neurological disorders where there is a deficiency of specific enzymes.
tamate residues in Con G are carboxylated and, in mammals, γ-glutamyl carboxylase encoded by the gene Ggcx is responsible for the mod-Recombinant Adeno-Associated Virus Transduction of Murine ification and expressed in all tissues. Hence, recombinant Con G in Brain Neuronal Precursor Cells mammalian cells is expected to undergo posttranslational modification in all cells. Because antibodies to these unique peptides are not com-K. Nash,* M. J. Berg, † P. Reid,* M. C. Cardenas-Aguayo, † mercially available, it was necessary to generate custom antibodies. N. Marks, † M. Gordon,* and D. Morgan* In Fluorophore-Linked Immunosorbent Assays (FLISA) with synthetic peptides, the resultant antibodies showed specificity and a concentra-*Byrd Alzheimer Institute, Molecular Pharmacology and Physiology, tion-dependent reaction. The anti-MVIIA antibody recognized cells expressing recombinant MVIIA using immunocytochemistry and the University of South Florida College of Medicine, Tampa, FL, USA anti-Con G antibody recognized venom granules in a section of the †Center for Dementia, Nathan Kline Institute, New York University, Conus geographus venom duct. These data suggest that the antibodies Orangeburg, NY, USA are authentic and can be used to identify both natural and synthetic Recombinant adeno-associated viruses (rAAV) provide tools to MVIIA and Con G, respectively. Transduction of rat spinal cord with manipulate gene expression of proteins relevant to neurodegeneration.
MVIIA resulted in robust expression of MVIIA for at least 4 weeks Stem cells provide a potential method for cell replacement therapy. evaluated thus far after injection, without apparent adverse effects. Here we examine rAAV's ability to transduce neural precursor cells These findings provide an avenue to explore conopeptide-based gene (NPC) from murine E13 embryonic brain areas destined to differentitherapy as a potential treatment for chronic SCI pain. ate into areas vulnerable to neurodegeneration. Transduction with Supported by the Ralph Wilson Medical Research Foundation. rAAV enables modification of gene expression in NPC cells for potential therapeutic applications. We evaluated transduction efficiency for rAAV serotypes 1, 2, 5, 8, and 9 encoding green fluorescent protein Life Span Extended and Motor Recovery in Glutaric Aciduria (GFP) with a cytomegalovirus (CMV)/chicken β-actin promoter, in Type-I Mice After Transplantation of Neural-Induced CD133 cultured NPCs derived from anterior brain destined to become primary Stem Cells From Human Umbilical Cord Blood neurons or glia. Transduction efficiency was assessed by fluorescence/ phase-contrast, cell differentiation by immunocytochemistry, and tox-M. B. Newman,* J. L. Zinnanti, † W. J. Zinnanti, ‡ icity by colony counts on long-term culture. NPCs were cultured 0-30 and R. A. E. Bakay* days in serum-free media plus epidermal growth factor (EGF) to limit terminal differentiation in the presence of 10 3 -10 5 viral genomes (VG) *Department of Neurosurgery, Rush University Medical Center, per cell. Transgene expression was observed 72 h postinfection with Chicago, IL, USA rank order of efficiency of 1 > 2 > 9 > 8 > 5. This compares with mini- †Department of Biology, Beckman Institute, California Institute mal detection after 10 days with intracerebral injections. Stable exof Technology, Pasadena, CA, USA pression of the transgene was detected for up to 30 days and signifi- ‡Department of Neurosurgery, Penn State College of Medicine, cant toxicity was only seen at higher viral titers. Data provide an in vitro model to rapidly determine infectivity of viral preparations for Hershey, PA, USA which none currently exist for most serotypes. We demonstrate that rAAV are excellent vehicles for modification of gene expression in Glutaric aciduria type I (GA-I) is a rare organic acid autosomal NPC for potential therapeutic applications.
recessive human disorder, in which there is an inborn error in the mitochondrial catabolism of L-lysine, L-hydroxylysine, and L-tryptophan that is caused by a deficiency of the enzyme glutaryl coenzyme-
Development of Conopeptide Gene Therapy Tools for Rodent
A dehydrogenase (Gcdh). In humans and in a mouse model of GA-I, Chronic Spinal Cord Injury Pain the accumulation of glutaric acid (GA), 3-hydroxyglutaric acid (3-OH-GA), glutarylcarnitine, and glutaconic acid is present in blood, urine, F. Nasiri Nezhad, M. E. Collado, L. M. Collado, S. Liu, D. Collante, CSF, or brain tissue. Both GA and 3-OH-GA are thought to induce L. Rusakova, M. Varghese, S. Jergova, S. Gajavelli, and J. Sagen imbalances in glutamatergic and GABAergic neurotransmission pathways, and 3-OH-GA may act through the excitotoxic NMDA receptors Pope Life Center, Miami Project to Cure Paralysis, University to produce a neurotoxic effect in the brain. Clinically, the disease course is not noticed until an acute encephalopathic crisis occurs, of Miami, Miami, FL, USA which is usually precipitated by an infectious disease, immunization, To accomplish this goal, we studied the R6/2 transgenic mouse model of Huntington disease (HD) to determine the concentrations of metab-or surgery during infancy or childhood. The current treatment is administration of riboflavin that assists in the breaking down and pro-olites within the striatal area of the brain. Thirteen R6/2 HD transgenic mice as well as 17 wild-type (WT) mice were studied using high field cessing of proteins, and a strict low-protein diet; however, approximately one third of children with GA-I do not respond to this diet in vivo proton NMR spectroscopy at 9.4 Tesla. We tested all four clustering methods: 1) with the original 30 mice, 2) with 31 unknown regime. Even those individuals under dietary management may still have metabolic crises and other detrimental effects. Currently, there mice, whose status had been determined via genotyping, and 3) with the ability to separate the original 13 R6/2 mice into two age sub-are no approved therapies for patients with GA-I disorder beside the strict diet. However, allogeneic and autologous stem cell transplants groups (8 and 12 weeks old). Supervised by ROC curve analysis, Fuzzy and K-means clustering passed all three stringent tests with a have been included as part of the overall therapy for some patients with other metabolic disorders (mucopolysaccharidoses and leukodys-total accuracy of 100% [positive likelihood ratio approximating infinity (1/0 = ∞ ) and negative likelihood ratio equal to zero (0/1 = 0)], trophies). Therefore, the objective of this study was to investigate and observe the transplantation of neural-induced CD133 (N-CD133) stem proving that they may be used for diagnostic purposes. Our aforementioned mathematical approaches are independent of HD and NMR cells, from human umbilical cord blood, into Gcdh knockout (−/−) mice, an animal model for GA-I. N-CD133 cells were transplanted in spectroscopy (i.e., they may be applied to any other disease state using any other technology). Gcdh−/− mice (1) before placement on high lysine diet, (2) after placement on this diet and with obvious motor deficits, and in age-matched (3) wild-type (WT) mice for controls. In addition, some (4) §Northwestern University Feinberg School of Medicine, planted Gcdh−/− mice. We are currently assessing the immunohisto-Chicago, IL, USA chemistry results and will present these at the meeting.
Supported in part by International Organization of Glutaric Aciduria (IOGA) created by Steven Goodman's laboratory.
A primary pathological component of Parkinson's disease (PD) is brain inflammation. Activation of microglia, the cellular component of the neuroinflammatory response, is capable of producing neuronal damage through the production of bioactive molecules such as cyto-Clustering Analyses for the Diagnosis of Huntington kines, as well as reactive nitrogen and oxygen species. The inflammaand Other Diseases tory response in the brain is normally tightly regulated in part by neurons, which produce molecules that can suppress the activation of J. B. Nikas* † and W. C. Low* ‡ § microglia. Fractalkine (FKN) is a neuronally produced chemokine that has a critical role in the regulation of excessive microglia activation. *Department of Neurosurgery, Medical School, University
With age there is a loss of FKN and this may make microglia primed for excessive activation, which is known to occur in age-related neuroof Minnesota, Minneapolis, MN, USA degenerative diseases including PD. While loss of FKN has been shown †Pharmaco-Neuro-Immunology Program, Medical School, University to result in excessive microglia activation, it is not known if addition of Minnesota, Minneapolis, MN, USA of exogenous FKN beyond otherwise physiologically normal levels of ‡Graduate Program in Neuroscience, Medical School, University FKN will be therapeutically beneficial following a neurotoxic insult. of Minnesota, Minneapolis, MN, USA
To test the hypothesis that the FKN signaling pathway could be a §Department of Integrative Biology and Physiology, Medical School, therapeutic target for neurodegeneration produced by microglia activa-University of Minnesota, Minneapolis, MN, USA tion, we used the intrastriatal 6-hydroxydopamine (6-OHDA) model of PD. Briefly, this model uses 6-OHDA (20 µg/4 µl) infused into the left striatum of 3-month-old F344 male rats (coordinates: AP +1, ML Nuclear magnetic resonance (NMR) spectroscopy has emerged as a technology that can provide information regarding quantitative levels +3, and V −4.5). Immediately after the 6-OHDA a stereotaxically implanted cannula, connected to an osmotic minipump, was affixed to of metabolites within organ systems in vivo. This technology permits the monitoring and analysis of metabolites associated with normal and the skull to allow for a sustained delivery of FKN for 28 days into the site of the lesion [Alzet model 2004: pumping rate 0.25 µl/h (±0.05 pathophysiological states. Because of the resolution of current high field NMR spectrometers there is an abundance of metabolic com-µl/h); total volume 1.0 ml]. To establish a dose response for FKN, 3 ng of FKN, 30 ng of FKN, 90 ng of FKN, or 90 ng of heat-inactivated pounds that can be used to assess progression of disease states and response to therapy. Conventional statistical tools are not designed to FKN (as a control) was infused via osmotic minipump. After 28 days the rats were anesthetized followed by transcardial perfusion with handle the complexity and volume of data that can be generated by NMR spectroscopy, and new approaches that can accomplish that task phosphate-buffered saline (PBS), then with 4% paraformaldehyde in PBS. Immunohistochemistry was performed for every third 40-µm-with speed and accuracy are required. In this study, we introduced the novel concept of employing a clustering method to render a differen-thick tissue sections for tyrosine hydroxylase (TH) and MHC class II (OX-6) throughout the entire dorsal striatum. Using the cavalieri tial diagnosis in a given disease state. We developed mathematical approaches that rendered the aforementioned novel concept a reality, method of unbiased stereology to calculate the TH-negative lesion volume revealed that exogenous soluble FKN was neuroprotective, result-and we devised three tests to assess the suitability and the accuracy required for diagnostic purposes of the four clustering methods we ing in a significantly smaller lesion. Importantly, FKN produced a dose-dependent decrease in activated microglia, supporting the pro-investigated (K-means, Fuzzy, Hierarchical, and Medoid Partitioning). posed mechanism of action. These findings demonstrated that FKN in the memory retrieval (probe) test conducted at 24 h after the last training session. The FST revealed that, in rats exposed to chemicals, plays a neuroprotective role in 6-OHDA-induced dopaminergic lesions and it might be an effective therapeutic target for many neurodegener-the overall depressive-like behavior was 51% greater than the vehicle group (p < 0.01). Thus, 28-day exposure to a combination of GWI-ative diseases, including Alzheimer' disease and PD, where inflammation plays an important role. related chemicals (PB, DEET, and permethrin) greatly diminishes hippocampal neurogenesis for prolonged periods, and impairs learning, This work was supported by the VA Medical Research Service (P.C.B.) . memory, and mood functions. Considering the purported role of hippocampal neurogenesis, it appears that a greatly declined hippocampal neurogenesis underlies learning and memory impairments and depression in GWI.
Declined Hippocampal Neurogenesis Is Associated Supported by a Gulf War Research Grant from the Department of With Learning & Memory Impairments and Depression
Veterans Affairs (A.K.S.) . in a Rat Model of Gulf War Illness Chicago, IL USA The Gulf war illness (GWI) in Persian Gulf War-1 (PGW-1) veter- †Department of Neurological Science, Rush University Medical ans manifests as a set of nonspecific symptoms with emphasis on central nervous system (CNS) impairments. The CNS impairments in-Center, Chicago, IL, USA clude cognitive dysfunction, memory loss, and depression and anxiety. During the PGW-1, the veterans were exposed to a mixture of biologi-Parkinson's disease (PD) is a progressive neurodegenerative disorcal and chemical environments. First, to protect against the nerve der, characterized by dopamine (DA) neuron loss in the substantia agents, the troops were given pyridostigmine bromide (PB) as a pronigra pars compacta (SNpc). Inflammatory mediators such as TNF-α phylactic treatment. Second, pesticides such as N,N-diethyl-m-tolu- and VEGF are upregulated in PD and are known to promote angiogenamide (DEET) and permethrin were widely used by troops to combat esis; the sprouting of new vessels from preexisting vessels. In previous insects/rodents in the region. From these viewpoints, it is supposed animal studies using toxin-induced models of PD, we showed that arthat the neurological symptoms exhibited by Gulf war veterans are eas exhibiting blood-brain barrier (BBB) disruption [assessed using owed to a synergistic interaction of chemicals PB, DEET, and perme-FITC-labeled albumin (FITC-LA) leakage into brain] also exhibited thrin. Considering the suggested functions of hippocampal neurogenincreased expression of integrin β3, a marker for angiogenesis. We esis in learning, memory, and mood, we investigated whether the cogalso showed upregulation of β3 integrin in autopsy samples from PD nitive dysfunction seen in GWI is linked to a greatly declined patients, suggesting angiogenesis may play a role in toxin induced hippocampal neurogenesis. A larger cohort of male Sprague-Dawley as well as idiopathic PD. Using the MPTP mouse model of PD, we (3-month-old) rats was exposed daily to chemicals DEET (40 mg/kg/ tested whether the angiogenic inhibitor, cyclo Arg-Gly-Asp-D-Pheday, dermal), permethrin (0.13 mg/kg/day, dermal), and PB (1.3 mg/ Val (cyRGDfV), was effective in reducing BBB dysfunction, preventkg/day, oral) for 28 days. A second cohort of age-matched rats received ing DA neuron loss and neuroinflammation. Mice were injected with vehicle during the same period and a third cohort of age-matched rats MPTP (10 mg/kg q 1 h × 4) or saline (SAL). Twenty-four hours later, served as naive controls. One day after the above exposure regimen, mice in each group were treated with SAL, cyRGDfV (100 µg/50 µl) subgroups of rats from all groups received four IP injections of 5′or cyRADfV (a negative control) two times/day for 3 consecutive bromodeoxyuridine (BrdU; one injection every 6 h over an 18-h pedays. Twenty-four hours following their last treatments, the animals riod) and were perfused at 6 h after the last injection for analyses of were assessed for FITC-LA leakage, DA neuron loss [tyrosine hydroxthe production of new cells per day. Three months after the exposure, ylase immunoreactive (TH-ir) cell counts], and microglia activation additional subgroups of rats were given 12 injections of BrdU (once (Iba-1 immunoreactive cell counts) in SNpc. MPTP treatment reduced daily over 12 days; 100 mg/kg) and perfused at 1 month after the TH-ir cell counts by 32% compared with SAL-treated mice [F(4, 20) = last BrdU injection to ascertain the long-term effects of the chemical 17.032, p < 0.001]. The TH-ir cell counts in MPTP + cyRGDfV-treated exposure. Separate subgroups of rats from all groups were tested for mice were unchanged relative to SAL-treated mice, but were markedly learning and memory function using a water maze test (WMT) at 2 increased relative to MPTP only and MPTP + cyRADfV-treated mice months after the exposure regimen. These rats were also examined for (p < 0.001), indicating that the angiogenic inhibitor completely blocked the extent of depression using the forced swim test (FST). Quantifica-DA neuron loss. MPTP and MPTP + cyRADfV-treated mice exhibited tion of BrdU + cells in subgranular zone-granule cell layer (SGZ-GCL) areas of punctate leakage of FITC-LA into the SNpc and striatum, revealed that the overall production of new cells/day diminishes by suggesting barrier compromise, whereas cyRGDfV posttreatment pre-40% at 1 day after the exposure regimen, in comparison to control vented barrier compromise. MPTP and MPTP + cyRADfV-treated mice groups (p < 0.001, n = 5/group). Measurement of the numbers of douexhibited marked increases in microglia cell counts that were comblecortin (DCX)-positive newly born neurons in the SGZ-GCL repletely prevented in MPTP − cyRGDfV-treated mice. cyRGDfV blocked vealed a similar trend. Furthermore, analyses of newly born cells in TH-ir cell loss, FITC-LA leakage, and microglial activation, indicating the SGZ-GCL at 3 months after the exposure regimen revealed that that angiogenesis may underlie the neuroinflammation-mediated disthe reductions seen in the production of new cells at an early time ruption of the BBB and DA neuron loss. This suggests that antiangiopoint persists for prolonged periods, as rats exposed to chemicals exgenic factors currently available or in cancer clinical trials may slow hibited 45% reduction in the production of new cells (p < 0.01; n = 5/ disease progression. group). Counting of DCX + newly born neurons also showed a similar Supported by NS052414 and Kenneth Douglas Foundation. trend (p < 0.001). Analyses using a WMT demonstrated learning and memory impairments in rats exposed to chemicals (n = 6/group). Delayed learning was evidenced by increased latency (in seconds) to find the hidden platform in all seven training sessions, in comparison to the vehicle group. Impaired memory was revealed by reduced dwell time in the target area (p < 0.05), fewer entries into the target area (p < 0.05) and increased latency to reach the target area (p < 0.001) Cancer stem cell biology has typically focused on cells that already hold promise as both a treatment for PD-associated depression and the exist in glioma; it has less extensively explored the cell-of-origin in a progression of the DA degeneration that occurs in PD. The primary manner that allows for the rigorous in vivo clonal analysis necessary objective of this study was to assess whether early antidepressant treatto begin distinguishing between fundamental models and mechanisms ment has disease-modifying effects in PD patients. We performed a of cerebral oncogenesis. Determining whether a tumor is polyclonal patient-level meta-analysis utilizing existing prospectively collected versus monoclonal would suggest a nonhierarchical versus hierarchical data from six completed clinical trials [from the Parkinson's Study process, respectively. To trace gliomagenesis, starting in the premalig-Group (PSG) and the NIH Exploratory Trials in Parkinson's Disease nant brains of newborn mice fated to develop tumors in adulthood, we Project (NET-PD)] to examine the extent to which antidepressant applied unbiased retroviral-mediated lineage and fate mapping techtreatment in PD patients delays the "need for dopaminergic therapy" niques in a well-characterized model for glioma. Identical, equipotent or changes the degree of motor impairment and disability. A total of neural stem cells (NSCs) in the subventricular zone (SVZ) of newborn 2,064 patients compiled from both treatment and placebo groups were GFAP-Ras mice were transduced in situ using a replication-incompeincluded in our study. Of these, 451 were taking some form of antidetent retrovirus carrying a complex oligonucleotide library comprised pressant. The primary outcome "time to dopaminergic therapy" was of 10 8 unique genetic inserts, each of which could be subsequently reported as days to initial use of dopaminergic therapy (levodopa, doidentified by PCR at the single cell level, allowing unequivocal assignpamine agonists, etc.). Preliminary results indicate that subjects taking ment of clonal relationships between cellular progeny that shared these any form of antidepressant showed a lower probability of requiring "tags." Glioma proved to be of polyclonal, nonhierarchical NSC origin dopaminergic therapy than those not taking antidepressants (HR = 0.6, with cell nonautonomous influences. Tumor-founding NSCs were inip = 0.0002). Furthermore, this effect was not specific to a particular tially indistinguishable from those yielding normal structures. Any class of antidepressant as subjects taking TCAs (HR = 0.5, p = 0.0009), cells with a proliferative advantage emerged late in the process while SSRIs (HR = 0.6, p = 0.001), or atypical antidepressants (HR = 0.5, already in the tumor. These data speak against the classic view of p = 0.02) showed a slower rate of time to dopaminergic therapy comcancer stem cells and the models for oncogenesis that they predict. pared to those not taking antidepressants. The secondary outcome, de-Furthermore, prior to developing tumors, NSCs evinced an altered difgree of motor impairment and disability, was reported as annualized ferentiation trajectory from principally a neuronal fate to one of inapchange in total UPDRS score from baseline to final visit. There was no propriate gliogenesis, resulting in a paucity of neurons in the olfactory significant difference in UPDRS scores for subjects taking any form of bulbs, the normal principal output of SVZ NSCs. These findings sugantidepressant (mean 11 point worsening) compared to those not takgest that oncogenesis may impact fundamental normal developmental ing antidepressants (mean 14 point worsening; p = 0.15). However, programs. Indeed, to the list of processes that can impair adult neurothere was a significant difference in UPDRS scores for patients taking genesis, cerebral oncogenesis may now need to be added. Small-moleatypical antidepressants (mean 7 point worsening) compared to those cule MEK inhibitors restored neurogenesis in vivo, with both murine not taking antidepressants (mean 14 point worsening; p < 0.05). These and human glioma cells subsequently showing reduced self-renewal results show that antidepressants, regardless of class, significantly and a switch to neuronal differentiation, suggesting this NSC-based slow the time to dopaminergic therapy in a population of early PD gliomagenic process to be reversible. patients. Also, subjects treated with atypical antidepressants exhibit a lesser degree of motor impairment and disability than those not taking antidepressants. Combined, these results suggest antidepressant ther-Adult Behavior After Neonatal mNPC Transplantation apy can provide additional therapeutic benefit for early PD patients in the Ts65Dn Mouse Model beyond treatment of depressive symptoms, thus providing a rationale for early intervention.
Antidepressant Treatment Alters the Temporal Course Lineage Mapping of Glioblastoma Suggests a Polyclonal Nonhierarchical Stem Cell Origin Influenced by a of Need for Levodopa Therapy in a Population of Early Parkinson's Patients Pharmacologically Reversible Neurogenic-to-Gliogenic Switch
A. Rachubinski, S. K. Cornelius, and K. Bjugstad
Supported by Parkinson's Study Group (PSG) and the Udall Center of Excellence in Parkinson's Disease Research at the University
University of Colorado, Denver, CO, USA of Cincinnati (NS58830).
Down syndrome (DS), the most common genetic cause of intellectual disability, is due to the triplication of human chromosome 21. One of the most incapacitating results of this overexpression of genes is the impairment in cognition, especially in learning acquisition, spatial tasks, and association tasks. Much of the cognitive decline associated with DS occurs in postnatal development. While current DS treatments are directed at restoring already impaired cognitive functions, a treat-358 ABSTRACTS ment used earlier in development may postpone or prevent the emerg-mg/kg, SC) to verify extent of nigrostriatal degeneration. Animals with >7 rotations/min were utilized in this study. hRPEC were grown in ing impairments. Neural progenitor cells (NPC) have been used in a wide range of disorders with promising results. The present study culture and attached to collagen microcarriers and mFVM tissue was dissected from E13.5 mouse embryos, then made into a single cell sought to determine if NPC could be used as a long-term treatment when implanted neonatally, before the DS brain undergoes abnormal suspension for transplantation. Rats were separated into three groups: group 1-FVM-hRPEC cotransplant, group 2-hRPEC attached to postnatal changes. The Ts65Dn mouse model of DS, which has delayed development and cognitive impairments, was used. On postnatal collagen microcarriers, and group 3-mFVM tissue with daily cyclosporine immunosuppression. The total cell count of each graft day 2 (PND2), trisomic and disomic littermate control male mice received a bilateral implantation into the hippocampus of 100,000 NPC was kept constant, as was the approximate number of microcarriers transplanted. Apomorphine-induced rotations, Vibrissae evoked fore-(C17.2 cell line) or saline. An additional control group was left unimplanted. At 14 weeks, the now adult mice began a series of behavior limb placement test, and stepping test were utilized to track behavioral improvement and the tests were administered every 2 weeks for a pe-tests designed to assess functioning in learning and memory regions of the brain most affected in DS. First, mice were tested in the single riod of 3 months. Apomorphine-induced rotation results show that group 1 animals had significant behavioral improvement (p = 0.0344) trial Plus maze, a spontaneous alternation task that uses novel alternations to gauge spatiotemporal memory. To further evaluate spatial compared to their pretransplant rotational scores. Groups 2 and 3 animals also showed improvements in rotational scores to a lesser extent memory, the Morris water maze (MWM) was used, which required mice to remember the location of a hidden platform in a pool. Finally, but not to the extent (p = 0.0707 and p = 0.0611, respectively). Group 1 animals showed significant improvement in the forelimb placement conditioned taste avoidance (CTA) was used to evaluate association learning, a classical conditioning task that relies on making a correla-test with a t-test value of p = 0.0065. Group 2 and group 3 also showed improvement, although the p-values were not significant (p = 0.221 tion between a novel flavor (conditioned stimulus, CS) and a feeling of nausea. In the Plus maze, trisomic mice were significantly impaired and p = 0.260, respectively). Taken together, these results suggest that the hRPEC cografts can successfully protect striatal mFVM grafts (p < 0.05). While not significant, trisomic mice treated with either NPC or saline had an increase in the number of novel alternations from host immune rejection up to 3 months and provide functional improvement against parkinsonism. compared to untreated trisomic mice, suggesting a potential for treatment to improve cognition in this task (p > 0.05). Trisomic mice re-This study was funded in part by NIHRO1NS42402, HRSADI BTH06321, and a grant with the Pennsylvania Department of Health mained impaired in the acquisition of the MWM and no significant effect of NPC or saline was found, regardless of karyotype (p > 0.05).
using Tobacco Settlement Funds. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpre-In CTA, all groups of mice learned the association and consumed significantly less CS on the second exposure compared to the first expotations, or conclusions. The authors also acknowledge partial funding of this project by the Penn State University Brain Repair Fund. sure, although the reduction for trisomic mice was less than the disomic mice (p < 0.05). Implantation of either NPC or saline did not significantly affect whether mice reduced their consumption of the CS on second exposure. Based on this general assessment of behavior, A Comprehensive, Multidisciplinary Description treatment with NPC did not significantly improve cognitive function of the Progressive Pathology Exhibited by the R6/2 in trisomic mice. Interestingly, the implantation of either saline or Mouse Model of Huntington's Disease NPC may have had a positive effect, albeit insignificant, on the simple spatial task (plus maze). However, mice failed to show improvement I. Rattray,* R. Gale, † B. Solanky,* G. Bates, † and M. Modo* in complex spatial tasks (MWM) and association learning (CTA). It is possible that penetration of the brain at PND2 elicits a response that is *Institute of Psychiatry, King's College London, London, UK still measurable 14 weeks later, potentially mediated by the injection- †Medical and Molecular Genetics, King's College London, London, UK induced growth factor release at a critical time in development. The implications of such a response may offer a new approach to treating Huntington's disease (HD) is an autosomal dominant neurodegenconditions early in development. erative disorder characterized by the occurrence of severe brain atrophy coupled with the development of deficits in motor ability and cognitive abnormalities. The transgenic R6/2 mouse line has been developed to model this disorder preclinically. Although a well-described
Cograft of Human Retinal Pigment Epithelial Cells (hRPEC)
mouse line, to date there has not been a comprehensive description of Protect Striatal Mouse Fetal Ventral Mesencephalic (mFVM) age-related changes in multiple behavioral measures, which are then Graft From Host Rejection and Provide Antiparkinsonian correlated with neuropathological abnormalities assessed through se-Behavioral Benefits rial, in vivo high-resolution magnetic resonance imaging (MRI). For this purpose, 20 male and 20 female R6/2 mice and wild-type litter-A. Rao, R. Ramachandra, K. Venkiteswaran, C. A. Lieu, mates (WT, CBAxC57Bl/6) were used. Mice were exposed to serial and T. Subramanian* in vivo MRI to quantify changes in regional brain volumetry and T2 relaxivity, along with MR spectroscopy to determine the striatal me-Departments of Neurology and Neural and Behavioral Sciences, tabolite profile. For MR measures, mice are scanned at 4, 8, 12, and 14 Pennsylvania State University College of Medicine, Hershey, PA, USA weeks of age. Between scanning sessions mice were tested for motor performance on the rotarod, for anxiety-like behavior in an open field, and cognitive performance in the passive avoidance test and cued/ Transplantation of fetal ventral mesencephalic (FVM) tissue has spontaneous alternation behavior in a swimming T-maze. At the final been extensively tested and shown to ameliorate the symptoms associ-MRI session, mice were culled and brains taken for postmortem quanated with Parkinson's disease (PD). However, the efficacy of FVM tification of pathological status. R6/2 mice developed motor deficits transplantation requires life-long systemic long-term immunosuppresbetween 4 and 8 weeks of age compared to WT mice, as determined sion and may be susceptible to neurodegeneration. hRPEC have been by the rotarod test. Correlating such behavioral changes with the varishown to secrete several neurotrophic factors, immunomodulators, and ous in vivo MR measures will provide a more detailed description of L-dopa. We have previously shown that hRPEC cografts are able to the functional and neuropathological changes that occur in this preclinprotect striatal FVM grafts from immunological rejection for a period ical HD mouse model. of 18 days. In the present study we investigated the hypothesis that the immunosuppressive and neurotrophic properties of hRPEC will help to protect the mFVM striatal graft and provide long-term recovery of function. Rats were rendered hemiparkinsonian by stereotactic injection of 6-hydroxydopamine into the medial forebrain bundle/substantia nigra. At 3 and 5 weeks, animals were exposed to apomorphine (0.2 A Behavioral, Histopatholgical, and Anatomical Characterization of cell passages may increase survivability. The goal of this present study was to compare the efficiency of low versus high number of of the CAG140 Huntington's Disease Mouse Model passages of cultured cells from two sources (bone marrow and umbilical cord blood cells) when transplanted into the striatum of R6/2 A. C. Rising,* E. Denovan-Wright, † and R. Mandel* mouse model of HD. Bilateral intrastriatal transplants (Tp; 400,000 cells/striatum) of MSCs in R6/2 mice were performed when the mice *Department of Neuroscience, Powell Gene Therapy Center, were 5 weeks old. A high passage ( ≥ 40) and a low passage (≤7) McKnight Brain Institute, University of Florida College of Medicine, populations of MSCs from both bone marrow and umbilical cord Gainesville, FL, USA blood were used for the Tps. Following surgery, all mice were tested †Department of Pharmacology, Dalhousie University, Halifax, Nova on a battery of tasks, which included assessments of clasping, rotarod, Scotia, Canada and the Morris water maze (MWM) performance. The animals were sacrificed by transcardial perfusions at 12 weeks of age (7 weeks after Huntington's disease (HD) is a neurodegenerative disease whose the transplantation). All R6/2 mice showed deficits on the rotarod behavioral, motor, and cognitive symptoms progress as the individual tasks, with those receiving the low-passaged MSCs having slightly ages. HD is caused by a poly-glutamine expansion in the huntingtin longer latencies to fall, relative to those receiving the high-passaged protein. The exact function of WT huntingtin is not known. Similarly, MSCs. Similarly, the MWM results revealed a decrease in distance the mechanism by which the poly-glutamine expansion causes the leswum to find the hidden platform for all HD mice transplanted with thal disease is not fully understood. The cloning of the HD gene has MSC Tps. Immunohistochemistry revealed that MSCs were viable allowed the creation of various mouse models of this disease and within the striatum at 7 weeks post-Tp, with GFAP astrocytes concengreatly increased our knowledge of the disease itself. Here we examine trated in the vicinity of the Tp site. MSCs tended to remain within the the behavioral, histopathological, and anatomical characteristics of the area of transplantation, and only a few MSCs expressed the neuronal CAG140 knock-in HD mouse model. This model has the repeat region marker NeuN. These results indicate transplantation of MSCs is able of the first exon that has been replaced with the human version that to reduce behavioral deficits in the R6/2 model of HD and support our contains 140 glutamine repeats. We have longitudinally examined the previous work that fewer passages tend to increase survivability and rearing behavior, accelerating rotarod, constant speed rotarod, and efficacy. These results suggest that MSCs may provide a promising open field behavior for the heterozygote, homozygote, and their wildtherapeutic approach for treating HD. type littermates and have found a significant deficit in the behavior of the afflicted mice. However, unlike the human disease, these behaviors do not appear to progressively get worse over time. Histopathologi-Novel Neurotrophic Factor CDNF: Biology cally, the CAG140 mice may model the HD disease better than the and Therapeutic Potential behavior observed in the mice. Neuronal intranuclear inclusions (NIIs) is a hallmark of the disease in humans as well as other HD models.
M. Saarma, P. Lindholm, J.-O. Andressoo, J. Peränen, We show here that the NIIs in the CAG140 mice significantly increase and M. Lindahl as the mice age. As in the human disease, we show that the CAG140 mice also have a significant decrease in specific mRNA transcripts Institute of Biotechnology, University of Helsinki, Helsinki, Finland localized to the striatum. Lastly, these HD mice show a progressive decrease in their cortical thickness, similar to what has recently been shown in humans with HD. The mice did not show a significant
In Parkinson's disease (PD) dopaminergic (DA) neurons located change in weight in any of the groups.
in the substantia nigra progressively degenerate and die. Available PD treatments are symptomatic and unable to slow down or stop neurodegeneration. Neurotrophic factors (NTFs) are critically important for the maintenance of neurons, and during trauma they are able to protect Mesenchymal Stem Cell Transplants Reduce Behavioral Deficits and induce the repair of neurons. Glial cell line-derived neurotrophic in the R6/2 Mouse Model of Huntington's Disease factor (GDNF) and its homologous protein neurturin (NRTN) are able not only to protect, but also to induce the repair of DA neurons in J. Rossignol,* † K. D. Fink,* K. K. Davis,* S. Cheng,* animal models of PD. Although both proteins work well in animal S. A. Lowrance,* J. J. Matchynski,* L. Lescaudron, ‡ § models of PD they also have limitations-they are unable to pass the and G. L. Dunbar* † blood-brain barrier and therefore for the treatment they should be delivered directly into the brain. In addition, they diffuse very poorly in *Field Neurosciences Institute, Saginaw, MI, USA the brain tissue and GDNF did not prevent the α-synuclein-induced †Program in Neuroscience, Central Michigan University, dopaminergic neurodegeneration in the genetic rat model of PD. Part Mt. Pleasant, MI, USA of these limitations may be overcome by using the new neurotrophic ‡INSERM U643, ITERT, CHU, Nantes, France factor recently discovered in our laboratory. Cerebral dopamine neuro- §Faculté des Sciences et des Techniques, Université de Nantes, France trophic factor (CDNF) and its homologous protein mesencephalic astrocyte-derived neurotrophic factor (MANF) together with the invertebrate homologous protein form a novel family of evolutionarily con-Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Although only palliative treatments (e.g., tetrabenzad-served NTFs. Analysis of the crystal structure revealed that MANF and CDNF proteins consist of two domains: an amino-terminal sa-ine) are currently available, promising new approaches (e.g., siRNA and stem cell therapy) offer significant hope. Presently, only experi-posin-like domain and a natively unfolded carboxy-terminal domain with a single disulphide bond, revealing a structurally novel group of mental treatments using transplanted embryonic/fetal cells have proven effective for slowing the progression of HD. However, ethical proteins. The N-terminal saposin-like domain is able to bind lipids. We have demonstrated that CDNF and MANF can protect and repair concerns, problems of availability of embryos, tumor formation, and rejection may limit the long-term viability of embryonic stem cell midbrain dopamine neurons in rodent models of PD more efficiently and specifically than any other known neurotrophic factor. CDNF and treatments. Mesenchymal stem cells (MSCs) exhibit the ability to differentiate into neural lineages, representing an attractive source for MANF diffuse much better in the rodent brain tissue than GDNF and in addition have a unique property to bind oxidized phospholipids. cell replacement therapy in neurological disorders, such as HD. Neural differentiation of MSCs is more difficult, but their ability to release The latter is the hallmark of neurodegeneration that is also known to contribute to the pathogenesis of PD. Thus, there are at least four neurotrophic factors (BDNF, NGF, CNTF) and their anti-inflammatory properties may be of benefit in neurological diseases by protecting naturally occurring NTFs that can not only slow down neurodegeneration, but can also repair and regenerate diseased DA neurons. Without host neurons from dysfunction and death. However, survival of transplanted MSCs has been a concern in some studies. Our previous work doubt, GDNF and NRTN, but in particular CDNF and MANF, have a potential in the treatment of PD. We are currently making efforts to (Rossignol et al., JCMM; 2009) suggested that reducing the number metabolites that are present in undifferentiated and differentiated Stem Cell Scoring System (SCSS) for Selection of Dominant Human Umbilical Cord-Derived Mesenchymal Stem Cells NSCs to elucidate potential biomarkers to identify NSCs and their differentiation. On these high-resolution MRS scans, undifferentiated (hUCB-MSCs) Against Senescence neural stem cells were metabolically more active than differentiated cells, with metabolite intensities being higher across the spectrum. As C. H. Song,* † J. J. Kim,* and J. J. Kim § expected, this was most striking in the choline region. The highly proliferative nature of stem cells resulted in a markedly higher phospho-*Department of Obstetrics and Gynecology, School of Medicine, choline level compared to differentiated cells. In addition to this differ-Chosun University, Gwangju, Korea ence, important changes were recognized in the myo-inositol, glucose, †JB Stem Cell Institute Inc., Chosun University, Gwangju, Korea and NAA regions. MRS of in vitro cell extracts therefore provides a ‡Biology, Natural Sciences, Chosun University, Gwangju, Korea potential way to characterize a specific neural stem cell marker or §Department of Anatomy, Chosun University, Gwangju, Korea "signature." If translated into in vivo studies this could prove to be a robust, noninvasive technique to assess the differentiation of transplanted cells in vivo.
These days hUCB-MSCs are generating huge interest because of their therapeutic implications in the physiological regeneration processes and transplantation therapies. The dominant hUCB-MSCs may Effects of Trophogel for Adhesion, Proliferation, serve as potential therapeutic agents in regenerative medicine, apart and Differentiation of Human Umbilical Cord from their immunosuppressive effects and their potential to generate Blood-Mesenchymal Stem Cells (hUCB-MSC) multiple cell lineages. The selection of dominant hUCB-MSCs is a prerequisite for cell survival and also a key factor for the differentiation of MSCs against senescence. To facilitate such a selection, we C. H. Song,* J. J. Kim,* J. Kim, † ‡ S. H. Kim, † ‡ and Y. G. Kim § devised a novel Stem Cell Scoring System (SCSS) based on multilineage differentiations, growth rates, morphologies, passages of cell cy-*Department of Obstetrics and Gynecology, Chosun University, cle, immunophenotypic analysis, differentiation, senescence-associ-Gwangju, Korea ated gene expression, ROS formation, and senescence-associated †Department of Anatomy, School of Medicine, Chosun University, siRNA gene including SA-β-Gal. The high-scoring dominant cells Gwangju, Korea (group A; score 7-10) survived 16 passages when compared to 12 ‡JB Stem Cell Institute Inc., College of Medicine, Chosun passages in the low-scoring group (group C; score 1-4). The multilin-University, Gwangju, Korea eage differentiations in vitro of the neurogenic, adipogenic, and os- §Biology, Natural Sciences, Chosun University, Gwangju, Korea teogenic lineages were 100%, 57.1%, and 37%, respectively, and the differentiations of all the lineages decreased with increasing passages To develop the potential enhancement of cellular adhesion, prolifwith differentiation of the adipogenic and osteogenic lineages decreaseration, and differentiation of human umbilical cord blood mesenchying more than that of neurogenic lineage. Quantification of MSCs at mal stem cells (hUCB-MSCs), trophogel, a three-dimensional matrix the levels of the cell cycle inhibitors showed that their senescence is derived from placenta, was used as a substrate and their interactions accompanied by increased expression of p21 and MMP1 as indicated were studied by comparing with two-dimensional culture systems.
by lower SCSS, but TRF1 is not associated with the senescence in this Furthermore, to identify what strategy allowed for maximum enhancesystem. Low scoring cells of SCSS showed increased SA-β-gal stainment of the growth capabilities from MSCs, we determined the potening and produced more ROS when compared with high-scoring cells tial effects of placental extracts (PLx) and antioxidants on proliferation of SCSS. The expression of siRNA also correlated well with the scores of hUCB-MSCs. UCB-MSC cells were seeded at 5,000 cells/cm 2 (5 × of the new system. The expressions were more inhibited in high-scor-10 4 cells/6 plate) in culture medium using trophogel. Then cell adheing cells than in low-scoring cells. These findings suggest that highsion, spreading, and proliferation were assayed, and total cellular RNA scoring hUCB-MSCs on SCSS may be useful agents in regeneration was extracted to allow for determination of the cell surface marker processes or in transplantation therapies at the levels of various tested expression in hUCB-MSCs. von Kossa stain and oil red O were used agreements. to assess the differentiation of hUCB-MSC on trophogel into osteoblasts and adipocytes. The proliferative capacity of MSCs was determined by utilizing four commercial placental hormones [chorionic Amplification of Brain Self-Repair by Stereotaxic Microlesions gonadotrophin (hCg), dexamethazone (Dex), estrogen (Es), and progesterone (Pg)] and four antioxidants [ascorbic acid (Aa), curcumin S. Song,* † S. Song, ‡ C. Chuanhai, § K. Li,* † V. Sava,* † (Cur), resveratrol (Rr), and pycnogenol (Pyc)] including placental ex-G. Arendash, ¶ and J. Sanchez-Ramos* † tracts (Plx) with nonradioactive spectrophotometeric quantification assays using Wst-1 proliferaton assay kit (Roche, Germany). The is-*Department of Neurology, University of South Florida College sues associated with hUCB-MSC adhesion and spreading were significantly greater on trophogel compared to control on surfaces cultured in of Medicine, Tampa, FL, USA vitro for 2 h. The proliferation growth was also dramatically increased †James A Haley Veterans Affairs Hospital, Tampa, FL, USA compared to both negative (plastic tissue culture polystyrene: 2.5×) ‡Feinberg School of Medicine, Northwesten University, and positive controls (collagen 1: 1.1× and laminin: 1.6×) on day 5
Chicago, IL, USA cultures. UCB'MSC expressed oct4 when grown on trophogel, a tran- §Department of Molecular Pharmacology and Physiology, University scriptional binding factor present in undifferentiated cells with high of South Florida College of Medicine, Tampa, FL, USA proliferative capacity with increased mRNA levels and these patterns ¶Department of Biology, University of South Florida College were clearly dependent upon the culture timing. This expression correof Medicine, Tampa, FL, USA lated with an increase in differentiation efficiency towards osteogenic and adipogenic phenotypes based on oil red O and Von Kossa staining. In addition, the results strongly suggest that Es and Pg with or without Greater understanding of mechanisms that regulate neurogenesis may ultimately lead to enhanced brain self-repair following trauma, Plx hormones may be useful stimulants for ex vivo expansion of hUCB-MSCs. In addition, ascorbic acid was also shown to be a good stroke, and neurodegenerative diseases. In this report, we studied the effects of stereotaxic microlesions on neurogenesis in multiple regions candidate for this hypothesis. Furthermore, the Plx supplemented with basic fibroblast growth factor (bFGF) increased proliferation of MSCs of adult mice brain. Over the last few years it has become clear that neurons are generated continuously from adult stem cells in "germinal significantly. We conclude that bFGF and Plx may play a critical part in the recruitment of MSC function and promotion. Finally, we assume zones" of the adult brain in rodents. The adult brain retains a reservoir of neural progenitors in the dentate gyrus (DG) of the hippocampus that trophogel may contribute to solving the problems associated with the proliferative capacity and differentiation of hUCB-MSCs. and the rostral subventricular zone (SVZ) that can proliferate in re-
